track name="H3K9me1 (@ All cell types) 200" url="http://chip-atlas.org/view?id=$$" gffTags="on"
chr1 726906 727017 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 642 . 726906 727017 144,255,0
chr1 726906 727025 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 768 . 726906 727025 255,236,0
chr1 31904629 31904907 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 694 . 31904629 31904907 197,255,0
chr1 38077359 38077405 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 748 . 38077359 38077405 252,255,0
chr1 91852792 91853102 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 91852792 91853102 255,0,0
chr1 91852816 91853061 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 636 . 91852816 91853061 138,255,0
chr1 91852847 91852989 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 401 . 91852847 91852989 0,255,100
chr1 91852849 91853041 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 345 . 91852849 91853041 0,255,158
chr1 91852870 91853059 ID=SRX012395;Name=H3K9me1%20(@%20CD4%2B%20T%20cells);Title=GSM417823:%20HS%20CD4%20Act%2018h%20%20H3K9me1;Cell%20group=Blood;
source_name=CD4%2B%20T%20cells;antigen=H3K9me1;antibody=ab8896; 399 . 91852870 91853059 0,255,103
chr1 121354113 121354484 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 801 . 121354113 121354484 255,202,0
chr1 121354132 121354475 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 815 . 121354132 121354475 255,188,0
chr1 121354252 121354373 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 574 . 121354252 121354373 75,255,0
chr1 121354269 121354369 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 389 . 121354269 121354369 0,255,113
chr1 121357806 121358155 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 121357806 121358155 255,0,0
chr1 121357822 121358150 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 121357822 121358150 255,0,0
chr1 121426715 121426997 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 586 . 121426715 121426997 87,255,0
chr1 121426731 121426959 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 514 . 121426731 121426959 14,255,0
chr1 121458787 121458896 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 544 . 121458787 121458896 44,255,0
chr1 121468113 121468225 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 679 . 121468113 121468225 182,255,0
chr1 121478647 121478686 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 377 . 121478647 121478686 0,255,125
chr1 121478779 121479077 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 628 . 121478779 121479077 130,255,0
chr1 121478810 121479088 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 678 . 121478810 121479088 181,255,0
chr1 121478857 121478973 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 265 . 121478857 121478973 0,255,239
chr1 121483138 121483455 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 467 . 121483138 121483455 0,255,33
chr1 121484066 121485524 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 1000 . 121484066 121485524 255,0,0
chr1 121484081 121484133 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 299 . 121484081 121484133 0,255,205
chr1 121484081 121484135 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 280 . 121484081 121484135 0,255,224
chr1 121484081 121484138 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 287 . 121484081 121484138 0,255,217
chr1 121484081 121484170 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 272 . 121484081 121484170 0,255,232
chr1 121484082 121484136 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 411 . 121484082 121484136 0,255,90
chr1 121484082 121484176 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 251 . 121484082 121484176 0,255,253
chr1 121484084 121485465 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 121484084 121485465 255,0,0
chr1 121484085 121485467 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 121484085 121485467 255,0,0
chr1 121484089 121484213 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 524 . 121484089 121484213 24,255,0
chr1 121484094 121485473 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 121484094 121485473 255,0,0
chr1 121484100 121485474 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 121484100 121485474 255,0,0
chr1 121484203 121485390 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 121484203 121485390 255,0,0
chr1 121484208 121485492 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 1000 . 121484208 121485492 255,0,0
chr1 121484211 121485392 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 121484211 121485392 255,0,0
chr1 121484296 121485546 ID=SRX205093;Name=H3K9me1%20(@%20A549);Title=GSM1038462:%20H3K9me1-a549-3d-treated%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;treated%20twice%20with=10%20ng/mL%20TNF%20and%202%20ng/mL%20TGF%20for%2048hr%20each;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 1000 . 121484296 121485546 255,0,0
chr1 121484310 121484350 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 253 . 121484310 121484350 0,255,251
chr1 121484311 121484349 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 281 . 121484311 121484349 0,255,223
chr1 121484311 121484350 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 274 . 121484311 121484350 0,255,230
chr1 121484311 121484351 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 288 . 121484311 121484351 0,255,216
chr1 121484313 121484351 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 301 . 121484313 121484351 0,255,202
chr1 121484393 121485399 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 975 . 121484393 121485399 255,25,0
chr1 121484397 121485396 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 945 . 121484397 121485396 255,56,0
chr1 121484397 121485405 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 783 . 121484397 121485405 255,221,0
chr1 121484398 121485400 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 963 . 121484398 121485400 255,37,0
chr1 121484403 121485396 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 907 . 121484403 121485396 255,94,0
chr1 121484424 121485408 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 976 . 121484424 121485408 255,24,0
chr1 121484440 121484479 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 267 . 121484440 121484479 0,255,237
chr1 121484441 121484477 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 255 . 121484441 121484477 0,255,249
chr1 121484441 121484478 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 290 . 121484441 121484478 0,255,214
chr1 121484442 121484480 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 302 . 121484442 121484480 0,255,201
chr1 121484443 121484479 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 275 . 121484443 121484479 0,255,229
chr1 121484513 121485410 ID=SRX005160;Name=H3K9me1%20(@%20CD36%2B);Title=NA;Cell%20group=Blood;
cell%20type=CD36%2B%20primary%20hematopoietic%20stem%20cells/progenitor%20cells%20(HSCs/HPCs)cells;chip%20antibody=H3K9me1; 827 . 121484513 121485410 255,176,0
chr1 121484522 121484691 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 426 . 121484522 121484691 0,255,75
chr1 121484523 121484560 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 257 . 121484523 121484560 0,255,247
chr1 121484524 121484561 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 284 . 121484524 121484561 0,255,220
chr1 121484525 121484563 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 291 . 121484525 121484563 0,255,213
chr1 121484526 121484561 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 295 . 121484526 121484561 0,255,209
chr1 121484527 121484562 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 276 . 121484527 121484562 0,255,228
chr1 121484599 121485395 ID=SRX012395;Name=H3K9me1%20(@%20CD4%2B%20T%20cells);Title=GSM417823:%20HS%20CD4%20Act%2018h%20%20H3K9me1;Cell%20group=Blood;
source_name=CD4%2B%20T%20cells;antigen=H3K9me1;antibody=ab8896; 844 . 121484599 121485395 255,159,0
chr1 121484606 121484693 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 304 . 121484606 121484693 0,255,199
chr1 121484607 121484679 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 257 . 121484607 121484679 0,255,247
chr1 121484607 121484693 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 284 . 121484607 121484693 0,255,220
chr1 121484608 121484695 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 277 . 121484608 121484695 0,255,227
chr1 121484608 121484695 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 292 . 121484608 121484695 0,255,212
chr1 121484744 121485411 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 431 . 121484744 121485411 0,255,70
chr1 121484751 121485222 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 309 . 121484751 121485222 0,255,194
chr1 121484752 121485220 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 289 . 121484752 121485220 0,255,215
chr1 121484752 121485223 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 297 . 121484752 121485223 0,255,207
chr1 121484752 121485410 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 282 . 121484752 121485410 0,255,222
chr1 121484753 121485409 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 265 . 121484753 121485409 0,255,239
chr1 121484801 121485351 ID=SRX005150;Name=H3K9me1%20(@%20Hematopoietic%20Stem%20Cells);Title=NA;Cell%20group=Blood;
cell%20type=CD133%2B%20primary%20hematopoietic%20stem%20cells/progenitor%20cells%20(HSCs/HPCs)cells;chip%20antibody=H3K9me1; 426 . 121484801 121485351 0,255,75
chr1 121485261 121485411 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 314 . 121485261 121485411 0,255,189
chr1 121485264 121485410 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 301 . 121485264 121485410 0,255,202
chr1 121485264 121485411 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 294 . 121485264 121485411 0,255,210
chr1 143283216 143283334 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 291 . 143283216 143283334 0,255,213
chr1 149035372 149035407 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 467 . 149035372 149035407 0,255,33
chr1 149035372 149035409 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 485 . 149035372 149035409 0,255,15
chr1 149035375 149035410 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 446 . 149035375 149035410 0,255,55
chr1 224201326 224201521 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 492 . 224201326 224201521 0,255,8
chr1 224201391 224201521 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 495 . 224201391 224201521 0,255,5
chr1 228745492 228745712 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 474 . 228745492 228745712 0,255,26
chr1 228758090 228758351 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 731 . 228758090 228758351 235,255,0
chr1 236260488 236260631 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 324 . 236260488 236260631 0,255,179
chr1 236260496 236260644 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 391 . 236260496 236260644 0,255,111
chr1 236260646 236260688 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 434 . 236260646 236260688 0,255,67
chr1 240348215 240348420 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 240348215 240348420 255,0,0
chr10 38778056 38778186 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 38778056 38778186 255,0,0
chr10 38778058 38778189 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 974 . 38778058 38778189 255,26,0
chr10 38778059 38778193 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 38778059 38778193 255,0,0
chr10 38778061 38778182 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 928 . 38778061 38778182 255,73,0
chr10 38778062 38778179 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 829 . 38778062 38778179 255,174,0
chr10 38778063 38778178 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 760 . 38778063 38778178 255,244,0
chr10 38778098 38778142 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 563 . 38778098 38778142 64,255,0
chr10 38778102 38778139 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 505 . 38778102 38778139 5,255,0
chr10 38778103 38778138 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 516 . 38778103 38778138 16,255,0
chr10 38785686 38785799 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 666 . 38785686 38785799 169,255,0
chr10 38806344 38806379 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 367 . 38806344 38806379 0,255,135
chr10 38806345 38806381 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 446 . 38806345 38806381 0,255,55
chr10 38872116 38872173 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 435 . 38872116 38872173 0,255,66
chr10 38872133 38872173 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 428 . 38872133 38872173 0,255,73
chr10 38872133 38872180 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 556 . 38872133 38872180 57,255,0
chr10 38872137 38872173 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 429 . 38872137 38872173 0,255,72
chr10 38881726 38881847 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 891 . 38881726 38881847 255,111,0
chr10 38881729 38882002 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 902 . 38881729 38882002 255,99,0
chr10 39079415 39079542 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 666 . 39079415 39079542 169,255,0
chr10 39094129 39094242 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 653 . 39094129 39094242 156,255,0
chr10 39107282 39107407 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 753 . 39107282 39107407 255,251,0
chr10 39121391 39121505 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 822 . 39121391 39121505 255,181,0
chr10 39125512 39125654 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 674 . 39125512 39125654 177,255,0
chr10 39125515 39125667 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 800 . 39125515 39125667 255,204,0
chr10 39125532 39125644 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 493 . 39125532 39125644 0,255,7
chr10 39125533 39125651 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 622 . 39125533 39125651 124,255,0
chr10 39125536 39125649 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 537 . 39125536 39125649 37,255,0
chr10 39125548 39125659 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 493 . 39125548 39125659 0,255,7
chr10 39128800 39128922 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 986 . 39128800 39128922 255,14,0
chr10 39128803 39128927 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 900 . 39128803 39128927 255,102,0
chr10 39128808 39128927 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 879 . 39128808 39128927 255,123,0
chr10 39128808 39128927 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 896 . 39128808 39128927 255,106,0
chr10 39128812 39128922 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 729 . 39128812 39128922 233,255,0
chr10 39128817 39128926 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 744 . 39128817 39128926 248,255,0
chr10 39138116 39138234 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 719 . 39138116 39138234 223,255,0
chr10 39138117 39138230 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 759 . 39138117 39138230 255,245,0
chr10 39138125 39138230 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 665 . 39138125 39138230 168,255,0
chr10 42356673 42356818 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 555 . 42356673 42356818 56,255,0
chr10 42356676 42356818 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 580 . 42356676 42356818 81,255,0
chr10 42356699 42356800 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 381 . 42356699 42356800 0,255,121
chr10 42356706 42356809 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 352 . 42356706 42356809 0,255,150
chr10 42356966 42357091 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 579 . 42356966 42357091 80,255,0
chr10 42356974 42357090 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 511 . 42356974 42357090 11,255,0
chr10 42364707 42364815 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 583 . 42364707 42364815 84,255,0
chr10 42384253 42384591 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 597 . 42384253 42384591 98,255,0
chr10 42384304 42384556 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 522 . 42384304 42384556 22,255,0
chr10 42384936 42385638 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 902 . 42384936 42385638 255,99,0
chr10 42384944 42385499 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 872 . 42384944 42385499 255,130,0
chr10 42384946 42385648 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42384946 42385648 255,0,0
chr10 42384950 42385663 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 989 . 42384950 42385663 255,11,0
chr10 42384953 42385670 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 871 . 42384953 42385670 255,131,0
chr10 42384958 42385673 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 830 . 42384958 42385673 255,173,0
chr10 42384967 42385255 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 392 . 42384967 42385255 0,255,110
chr10 42385158 42385278 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 517 . 42385158 42385278 17,255,0
chr10 42385158 42385280 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 560 . 42385158 42385280 61,255,0
chr10 42385161 42385288 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 609 . 42385161 42385288 111,255,0
chr10 42385162 42385278 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 518 . 42385162 42385278 18,255,0
chr10 42385165 42385277 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 466 . 42385165 42385277 0,255,34
chr10 42385204 42385246 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 226 . 42385204 42385246 0,230,255
chr10 42385557 42385657 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 414 . 42385557 42385657 0,255,87
chr10 42385557 42385681 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 621 . 42385557 42385681 123,255,0
chr10 42385559 42385662 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 510 . 42385559 42385662 10,255,0
chr10 42387063 42387424 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 624 . 42387063 42387424 126,255,0
chr10 42387065 42387440 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 992 . 42387065 42387440 255,8,0
chr10 42391508 42391783 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 710 . 42391508 42391783 214,255,0
chr10 42391520 42391785 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 497 . 42391520 42391785 0,255,3
chr10 42395875 42396205 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 714 . 42395875 42396205 218,255,0
chr10 42395881 42396257 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42395881 42396257 255,0,0
chr10 42395908 42396246 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 573 . 42395908 42396246 74,255,0
chr10 42395931 42396242 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 562 . 42395931 42396242 63,255,0
chr10 42395931 42396248 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 511 . 42395931 42396248 11,255,0
chr10 42395949 42396255 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 523 . 42395949 42396255 23,255,0
chr10 42396018 42396168 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 255 . 42396018 42396168 0,255,249
chr10 42396040 42396200 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 583 . 42396040 42396200 84,255,0
chr10 42396068 42396187 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 476 . 42396068 42396187 0,255,24
chr10 42396069 42396186 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 494 . 42396069 42396186 0,255,6
chr10 42396070 42396184 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 452 . 42396070 42396184 0,255,48
chr10 42396070 42396188 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 467 . 42396070 42396188 0,255,33
chr10 42398509 42398881 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42398509 42398881 255,0,0
chr10 42398517 42398858 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 997 . 42398517 42398858 255,3,0
chr10 42398591 42398778 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 358 . 42398591 42398778 0,255,144
chr10 42398593 42398782 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 320 . 42398593 42398782 0,255,183
chr10 42398594 42398783 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 382 . 42398594 42398783 0,255,120
chr10 42398596 42398788 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 327 . 42398596 42398788 0,255,176
chr10 42398625 42398734 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 305 . 42398625 42398734 0,255,198
chr10 42399274 42399494 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 375 . 42399274 42399494 0,255,127
chr10 42399279 42399490 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 339 . 42399279 42399490 0,255,164
chr10 42399280 42399492 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 395 . 42399280 42399492 0,255,107
chr10 42399282 42399488 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 324 . 42399282 42399488 0,255,179
chr10 42400197 42400484 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 597 . 42400197 42400484 98,255,0
chr10 42400201 42400681 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42400201 42400681 255,0,0
chr10 42400209 42400679 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42400209 42400679 255,0,0
chr10 42400210 42400684 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 580 . 42400210 42400684 81,255,0
chr10 42400214 42400679 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 42400214 42400679 255,0,0
chr10 42400214 42400714 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42400214 42400714 255,0,0
chr10 42400216 42400660 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 934 . 42400216 42400660 255,67,0
chr10 42400220 42400680 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 855 . 42400220 42400680 255,147,0
chr10 42400226 42400697 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42400226 42400697 255,0,0
chr10 42400384 42400683 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 573 . 42400384 42400683 74,255,0
chr10 42400389 42400687 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 598 . 42400389 42400687 99,255,0
chr10 42400389 42400690 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 668 . 42400389 42400690 171,255,0
chr10 42400584 42400692 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 557 . 42400584 42400692 58,255,0
chr10 42408174 42408397 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 772 . 42408174 42408397 255,232,0
chr10 42408210 42408356 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 42408210 42408356 255,0,0
chr10 42408224 42408330 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 668 . 42408224 42408330 171,255,0
chr10 42408225 42408329 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 649 . 42408225 42408329 151,255,0
chr10 42408227 42408341 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 634 . 42408227 42408341 136,255,0
chr10 42409196 42409310 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 619 . 42409196 42409310 121,255,0
chr10 42409206 42409494 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 554 . 42409206 42409494 55,255,0
chr10 42409244 42409278 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 343 . 42409244 42409278 0,255,160
chr10 42527932 42528152 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42527932 42528152 255,0,0
chr10 42527984 42528101 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 837 . 42527984 42528101 255,166,0
chr10 42527985 42528091 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 643 . 42527985 42528091 145,255,0
chr10 42527986 42528093 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 657 . 42527986 42528093 160,255,0
chr10 42527988 42528093 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 636 . 42527988 42528093 138,255,0
chr10 42527990 42528091 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 603 . 42527990 42528091 105,255,0
chr10 42528007 42528077 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 432 . 42528007 42528077 0,255,69
chr10 42528009 42528077 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 273 . 42528009 42528077 0,255,231
chr10 42528009 42528078 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 319 . 42528009 42528078 0,255,184
chr10 42528010 42528075 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 283 . 42528010 42528075 0,255,221
chr10 42528011 42528074 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 300 . 42528011 42528074 0,255,204
chr10 42528011 42528078 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 277 . 42528011 42528078 0,255,227
chr10 42529228 42529853 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 42529228 42529853 255,0,0
chr10 42529229 42529864 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42529229 42529864 255,0,0
chr10 42529231 42529749 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42529231 42529749 255,0,0
chr10 42529233 42529857 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 952 . 42529233 42529857 255,48,0
chr10 42529236 42529728 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42529236 42529728 255,0,0
chr10 42529239 42529713 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42529239 42529713 255,0,0
chr10 42529263 42529740 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 753 . 42529263 42529740 255,251,0
chr10 42529268 42529633 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 802 . 42529268 42529633 255,201,0
chr10 42529271 42529634 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 863 . 42529271 42529634 255,139,0
chr10 42529273 42529632 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 766 . 42529273 42529632 255,238,0
chr10 42529273 42529633 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 768 . 42529273 42529633 255,236,0
chr10 42529286 42529638 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 42529286 42529638 255,0,0
chr10 42529290 42529631 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 804 . 42529290 42529631 255,199,0
chr10 42529331 42529685 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 392 . 42529331 42529685 0,255,110
chr10 42529379 42529487 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 359 . 42529379 42529487 0,255,143
chr10 42530582 42530695 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 387 . 42530582 42530695 0,255,115
chr10 42532484 42532588 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 470 . 42532484 42532588 0,255,30
chr10 42532486 42532590 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 503 . 42532486 42532590 3,255,0
chr10 42534493 42534766 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42534493 42534766 255,0,0
chr10 42534509 42534770 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42534509 42534770 255,0,0
chr10 42539951 42540014 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 266 . 42539951 42540014 0,255,238
chr10 42542981 42543081 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 565 . 42542981 42543081 66,255,0
chr10 42542981 42543082 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 581 . 42542981 42543082 82,255,0
chr10 42543002 42543075 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 297 . 42543002 42543075 0,255,207
chr10 42544621 42544788 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 524 . 42544621 42544788 24,255,0
chr10 42545950 42546194 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 715 . 42545950 42546194 219,255,0
chr10 42545969 42546195 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 959 . 42545969 42546195 255,41,0
chr10 42546018 42546147 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 883 . 42546018 42546147 255,119,0
chr10 42546030 42546145 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 716 . 42546030 42546145 220,255,0
chr10 42546031 42546147 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 772 . 42546031 42546147 255,232,0
chr10 42546033 42546145 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 683 . 42546033 42546145 186,255,0
chr10 42546035 42546147 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 692 . 42546035 42546147 195,255,0
chr10 42546038 42546153 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 794 . 42546038 42546153 255,210,0
chr10 42546043 42546136 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 386 . 42546043 42546136 0,255,116
chr10 42546047 42546137 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 317 . 42546047 42546137 0,255,186
chr10 42546051 42546141 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 451 . 42546051 42546141 0,255,49
chr10 42596793 42597284 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42596793 42597284 255,0,0
chr10 42596794 42597311 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42596794 42597311 255,0,0
chr10 42596812 42597261 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 42596812 42597261 255,0,0
chr10 42596818 42597222 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42596818 42597222 255,0,0
chr10 42596819 42597180 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 485 . 42596819 42597180 0,255,15
chr10 42596819 42597260 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 42596819 42597260 255,0,0
chr10 42596821 42597238 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42596821 42597238 255,0,0
chr10 42596821 42597242 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 1000 . 42596821 42597242 255,0,0
chr10 42596871 42597191 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 42596871 42597191 255,0,0
chr10 42596876 42597182 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 832 . 42596876 42597182 255,171,0
chr10 42596893 42597184 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 882 . 42596893 42597184 255,120,0
chr10 42596894 42597188 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 904 . 42596894 42597188 255,97,0
chr10 42596897 42597182 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 888 . 42596897 42597182 255,114,0
chr10 42596898 42596936 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 275 . 42596898 42596936 0,255,229
chr10 42596899 42597182 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 950 . 42596899 42597182 255,51,0
chr10 42597034 42597079 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 248 . 42597034 42597079 0,252,255
chr10 42597035 42597080 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 253 . 42597035 42597080 0,255,251
chr10 42597035 42597163 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 414 . 42597035 42597163 0,255,87
chr10 42597036 42597079 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 274 . 42597036 42597079 0,255,230
chr10 42597038 42597076 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 235 . 42597038 42597076 0,239,255
chr10 42597508 42598191 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 790 . 42597508 42598191 255,214,0
chr10 42597519 42597561 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 298 . 42597519 42597561 0,255,206
chr10 42597523 42597565 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 240 . 42597523 42597565 0,244,255
chr10 42597523 42597568 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 246 . 42597523 42597568 0,250,255
chr10 42597523 42597569 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 273 . 42597523 42597569 0,255,231
chr10 42597524 42597568 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 234 . 42597524 42597568 0,238,255
chr10 42597537 42598172 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 572 . 42597537 42598172 73,255,0
chr10 42597543 42598183 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 842 . 42597543 42598183 255,161,0
chr10 42597585 42598179 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 473 . 42597585 42598179 0,255,27
chr10 42597688 42598055 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 337 . 42597688 42598055 0,255,166
chr10 42597734 42598107 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 420 . 42597734 42598107 0,255,81
chr10 42597747 42598072 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 295 . 42597747 42598072 0,255,209
chr10 42598028 42598192 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 575 . 42598028 42598192 76,255,0
chr10 42598031 42598118 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 234 . 42598031 42598118 0,238,255
chr10 42598031 42598119 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 273 . 42598031 42598119 0,255,231
chr10 42598032 42598112 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 240 . 42598032 42598112 0,244,255
chr10 42598032 42598118 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 253 . 42598032 42598118 0,255,251
chr10 42598033 42598172 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 612 . 42598033 42598172 114,255,0
chr10 42598034 42598103 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 204 . 42598034 42598103 0,208,255
chr10 42598038 42598120 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 359 . 42598038 42598120 0,255,143
chr10 42599491 42600377 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42599491 42600377 255,0,0
chr10 42599493 42600288 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 42599493 42600288 255,0,0
chr10 42599500 42600252 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 42599500 42600252 255,0,0
chr10 42599500 42600282 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 42599500 42600282 255,0,0
chr10 42599507 42600048 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 661 . 42599507 42600048 164,255,0
chr10 42599511 42600400 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42599511 42600400 255,0,0
chr10 42599530 42600091 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 865 . 42599530 42600091 255,137,0
chr10 42599532 42600414 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 42599532 42600414 255,0,0
chr10 42599574 42600074 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 904 . 42599574 42600074 255,97,0
chr10 42599575 42600209 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 803 . 42599575 42600209 255,200,0
chr10 42599578 42600077 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 751 . 42599578 42600077 255,253,0
chr10 42599579 42600207 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 805 . 42599579 42600207 255,198,0
chr10 42599581 42600208 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 791 . 42599581 42600208 255,213,0
chr10 42599585 42600204 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 783 . 42599585 42600204 255,221,0
chr10 42599625 42599682 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 385 . 42599625 42599682 0,255,117
chr10 42599630 42599674 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 246 . 42599630 42599674 0,250,255
chr10 42599631 42599673 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 252 . 42599631 42599673 0,255,252
chr10 42599632 42599673 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 264 . 42599632 42599673 0,255,240
chr10 42599632 42599675 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 233 . 42599632 42599675 0,237,255
chr10 42599751 42599805 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 252 . 42599751 42599805 0,255,252
chr10 42599754 42599806 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 239 . 42599754 42599806 0,243,255
chr10 42599755 42599808 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 271 . 42599755 42599808 0,255,233
chr10 42599756 42599806 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 233 . 42599756 42599806 0,237,255
chr10 42599756 42599807 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 403 . 42599756 42599807 0,255,98
chr10 42599758 42599802 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 203 . 42599758 42599802 0,207,255
chr10 42599908 42599945 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 263 . 42599908 42599945 0,255,241
chr10 42599909 42599946 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 246 . 42599909 42599946 0,250,255
chr10 42599910 42599946 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 252 . 42599910 42599946 0,255,252
chr10 42818145 42818263 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 591 . 42818145 42818263 92,255,0
chr10 98561413 98561522 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 373 . 98561413 98561522 0,255,129
chr10 105010700 105010806 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 359 . 105010700 105010806 0,255,143
chr10 119941176 119941236 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 559 . 119941176 119941236 60,255,0
chr10 119941182 119941232 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 556 . 119941182 119941232 57,255,0
chr10 119941183 119941234 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 479 . 119941183 119941234 0,255,21
chr10 119941183 119941236 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 560 . 119941183 119941236 61,255,0
chr10 119941184 119941226 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 471 . 119941184 119941226 0,255,29
chr10 135490967 135491180 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 574 . 135490967 135491180 75,255,0
chr10 135500174 135501153 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 135500174 135501153 255,0,0
chr10 135500418 135501117 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 135500418 135501117 255,0,0
chr10 135501001 135501123 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 725 . 135501001 135501123 229,255,0
chr11 585237 585664 ID=SRX005150;Name=H3K9me1%20(@%20Hematopoietic%20Stem%20Cells);Title=NA;Cell%20group=Blood;
cell%20type=CD133%2B%20primary%20hematopoietic%20stem%20cells/progenitor%20cells%20(HSCs/HPCs)cells;chip%20antibody=H3K9me1; 733 . 585237 585664 237,255,0
chr11 585271 585645 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 585271 585645 255,0,0
chr11 585292 585612 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 887 . 585292 585612 255,115,0
chr11 585367 585535 ID=SRX005160;Name=H3K9me1%20(@%20CD36%2B);Title=NA;Cell%20group=Blood;
cell%20type=CD36%2B%20primary%20hematopoietic%20stem%20cells/progenitor%20cells%20(HSCs/HPCs)cells;chip%20antibody=H3K9me1; 358 . 585367 585535 0,255,144
chr11 1092855 1092964 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 375 . 1092855 1092964 0,255,127
chr11 3675014 3676021 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 3675014 3676021 255,0,0
chr11 3675074 3675213 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 254 . 3675074 3675213 0,255,250
chr11 3675426 3675916 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 526 . 3675426 3675916 26,255,0
chr11 3675426 3675917 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 490 . 3675426 3675917 0,255,10
chr11 3675477 3675909 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 869 . 3675477 3675909 255,133,0
chr11 3675486 3675904 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 870 . 3675486 3675904 255,132,0
chr11 3675620 3675829 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 458 . 3675620 3675829 0,255,42
chr11 3675701 3675822 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 355 . 3675701 3675822 0,255,147
chr11 10529455 10529495 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 432 . 10529455 10529495 0,255,69
chr11 10530771 10530824 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 513 . 10530771 10530824 13,255,0
chr11 10530776 10530826 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 516 . 10530776 10530826 16,255,0
chr11 10531052 10531087 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 422 . 10531052 10531087 0,255,79
chr11 10531163 10531243 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 361 . 10531163 10531243 0,255,141
chr11 48888351 48888385 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 543 . 48888351 48888385 43,255,0
chr11 51569976 51570224 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 809 . 51569976 51570224 255,194,0
chr11 51569976 51570240 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 781 . 51569976 51570240 255,223,0
chr11 51570055 51570164 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 584 . 51570055 51570164 85,255,0
chr11 51572074 51572204 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 939 . 51572074 51572204 255,62,0
chr11 51572081 51572196 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 689 . 51572081 51572196 192,255,0
chr11 51572090 51572195 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 718 . 51572090 51572195 222,255,0
chr11 51572092 51572196 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 702 . 51572092 51572196 206,255,0
chr11 51579363 51579740 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 897 . 51579363 51579740 255,105,0
chr11 51579366 51579764 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 51579366 51579764 255,0,0
chr11 51579369 51579743 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 51579369 51579743 255,0,0
chr11 51579374 51579759 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 906 . 51579374 51579759 255,95,0
chr11 51579386 51579695 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51579386 51579695 255,0,0
chr11 51579417 51579699 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51579417 51579699 255,0,0
chr11 51579522 51579676 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 742 . 51579522 51579676 246,255,0
chr11 51579534 51579673 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 51579534 51579673 255,0,0
chr11 51579536 51579671 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 962 . 51579536 51579671 255,38,0
chr11 51579540 51579673 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 993 . 51579540 51579673 255,7,0
chr11 51579542 51579672 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 906 . 51579542 51579672 255,95,0
chr11 51579544 51579686 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 999 . 51579544 51579686 255,1,0
chr11 51579609 51579643 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 432 . 51579609 51579643 0,255,69
chr11 51580078 51580701 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51580078 51580701 255,0,0
chr11 51580079 51580766 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51580079 51580766 255,0,0
chr11 51582560 51583064 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51582560 51583064 255,0,0
chr11 51582586 51583067 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51582586 51583067 255,0,0
chr11 51582680 51582981 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 450 . 51582680 51582981 0,255,51
chr11 51582699 51582992 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 536 . 51582699 51582992 36,255,0
chr11 51582702 51583000 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 504 . 51582702 51583000 4,255,0
chr11 51582703 51583004 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 478 . 51582703 51583004 0,255,22
chr11 51582709 51582998 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 787 . 51582709 51582998 255,217,0
chr11 51582712 51582995 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 920 . 51582712 51582995 255,81,0
chr11 51582861 51582984 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 496 . 51582861 51582984 0,255,4
chr11 51582873 51582933 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 286 . 51582873 51582933 0,255,218
chr11 51582873 51582934 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 296 . 51582873 51582934 0,255,208
chr11 51582875 51582931 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 332 . 51582875 51582931 0,255,171
chr11 51582875 51582934 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 300 . 51582875 51582934 0,255,204
chr11 51582880 51582929 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 304 . 51582880 51582929 0,255,199
chr11 51582886 51582930 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 313 . 51582886 51582930 0,255,190
chr11 51584895 51585007 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 659 . 51584895 51585007 162,255,0
chr11 51584922 51584977 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 278 . 51584922 51584977 0,255,226
chr11 51584922 51584979 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 306 . 51584922 51584979 0,255,197
chr11 51584923 51584975 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 339 . 51584923 51584975 0,255,164
chr11 51584923 51584978 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 308 . 51584923 51584978 0,255,195
chr11 51584925 51584978 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 372 . 51584925 51584978 0,255,130
chr11 51586744 51587072 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51586744 51587072 255,0,0
chr11 51586755 51587064 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51586755 51587064 255,0,0
chr11 51586813 51587054 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 913 . 51586813 51587054 255,88,0
chr11 51586814 51587048 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 689 . 51586814 51587048 192,255,0
chr11 51586830 51587006 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 579 . 51586830 51587006 80,255,0
chr11 51586830 51587012 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 564 . 51586830 51587012 65,255,0
chr11 51586831 51587003 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 514 . 51586831 51587003 14,255,0
chr11 51586836 51587017 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 534 . 51586836 51587017 34,255,0
chr11 51586837 51586910 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 327 . 51586837 51586910 0,255,176
chr11 51586843 51586908 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 312 . 51586843 51586908 0,255,191
chr11 51586843 51586909 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 308 . 51586843 51586909 0,255,195
chr11 51586966 51587020 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 219 . 51586966 51587020 0,223,255
chr11 51586974 51587021 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 280 . 51586974 51587021 0,255,224
chr11 51586975 51587016 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 264 . 51586975 51587016 0,255,240
chr11 51586987 51587023 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 252 . 51586987 51587023 0,255,252
chr11 51588771 51589135 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51588771 51589135 255,0,0
chr11 51588786 51589125 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51588786 51589125 255,0,0
chr11 51588831 51589126 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 593 . 51588831 51589126 94,255,0
chr11 51588856 51589106 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 942 . 51588856 51589106 255,59,0
chr11 51588858 51589104 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 793 . 51588858 51589104 255,211,0
chr11 51588870 51589076 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 587 . 51588870 51589076 88,255,0
chr11 51588876 51589059 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 624 . 51588876 51589059 126,255,0
chr11 51588876 51589062 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 556 . 51588876 51589062 57,255,0
chr11 51588880 51589060 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 589 . 51588880 51589060 90,255,0
chr11 51588883 51588956 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 269 . 51588883 51588956 0,255,235
chr11 51588885 51588955 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 322 . 51588885 51588955 0,255,181
chr11 51588885 51588959 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 333 . 51588885 51588959 0,255,170
chr11 51588888 51588957 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 314 . 51588888 51588957 0,255,189
chr11 51588916 51588959 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 317 . 51588916 51588959 0,255,186
chr11 51589012 51589062 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 251 . 51589012 51589062 0,255,253
chr11 51589013 51589068 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 261 . 51589013 51589068 0,255,243
chr11 51589014 51589070 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 287 . 51589014 51589070 0,255,217
chr11 51589022 51589068 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 254 . 51589022 51589068 0,255,250
chr11 51589028 51589063 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 225 . 51589028 51589063 0,229,255
chr11 51589028 51589070 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 293 . 51589028 51589070 0,255,211
chr11 51590324 51591279 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51590324 51591279 255,0,0
chr11 51590329 51590653 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51590329 51590653 255,0,0
chr11 51590370 51590569 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 464 . 51590370 51590569 0,255,36
chr11 51590372 51590566 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 375 . 51590372 51590566 0,255,127
chr11 51590374 51590573 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 455 . 51590374 51590573 0,255,45
chr11 51590379 51590569 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 414 . 51590379 51590569 0,255,87
chr11 51590381 51590555 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 351 . 51590381 51590555 0,255,151
chr11 51590826 51591264 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 51590826 51591264 255,0,0
chr11 51590894 51591182 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 487 . 51590894 51591182 0,255,13
chr11 51590894 51591191 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 803 . 51590894 51591191 255,200,0
chr11 51590896 51591292 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 805 . 51590896 51591292 255,198,0
chr11 51590899 51591188 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 517 . 51590899 51591188 17,255,0
chr11 51590900 51591186 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 543 . 51590900 51591186 43,255,0
chr11 51590901 51591196 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 941 . 51590901 51591196 255,60,0
chr11 51590912 51591245 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 699 . 51590912 51591245 202,255,0
chr11 51590917 51591217 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 599 . 51590917 51591217 100,255,0
chr11 51590921 51591295 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 616 . 51590921 51591295 118,255,0
chr11 51591044 51591181 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 598 . 51591044 51591181 99,255,0
chr11 51591059 51591119 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 269 . 51591059 51591119 0,255,235
chr11 51591060 51591123 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 314 . 51591060 51591123 0,255,189
chr11 51591061 51591118 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 308 . 51591061 51591118 0,255,195
chr11 51591064 51591116 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 275 . 51591064 51591116 0,255,229
chr11 51591064 51591117 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 343 . 51591064 51591117 0,255,160
chr11 51591068 51591121 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 337 . 51591068 51591121 0,255,166
chr11 51593103 51593140 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 301 . 51593103 51593140 0,255,202
chr11 51593103 51593140 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 336 . 51593103 51593140 0,255,167
chr11 51593104 51593139 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 307 . 51593104 51593139 0,255,196
chr11 51593106 51593141 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 285 . 51593106 51593141 0,255,219
chr11 51593108 51593143 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 390 . 51593108 51593143 0,255,112
chr11 68767838 68768216 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 322 . 68767838 68768216 0,255,181
chr11 68774433 68774828 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 321 . 68774433 68774828 0,255,182
chr11 68794904 68795544 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 412 . 68794904 68795544 0,255,89
chr11 68808717 68809763 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 494 . 68808717 68809763 0,255,6
chr11 68923973 68924420 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 297 . 68923973 68924420 0,255,207
chr11 69055561 69056054 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 381 . 69055561 69056054 0,255,121
chr11 69064458 69065073 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 361 . 69064458 69065073 0,255,141
chr11 69073247 69073782 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 318 . 69073247 69073782 0,255,185
chr11 69141565 69141885 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 257 . 69141565 69141885 0,255,247
chr11 69151623 69152888 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 575 . 69151623 69152888 76,255,0
chr11 69166219 69166543 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 290 . 69166219 69166543 0,255,214
chr11 69218267 69218709 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 309 . 69218267 69218709 0,255,194
chr11 69241547 69242144 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 489 . 69241547 69242144 0,255,11
chr11 69257360 69257963 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 356 . 69257360 69257963 0,255,146
chr11 69274687 69275282 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 356 . 69274687 69275282 0,255,146
chr11 69284850 69285459 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 477 . 69284850 69285459 0,255,23
chr11 69295023 69295585 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 478 . 69295023 69295585 0,255,22
chr11 69356285 69356955 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 563 . 69356285 69356955 64,255,0
chr11 69454566 69454940 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 462 . 69454566 69454940 0,255,38
chr11 69489020 69489330 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 284 . 69489020 69489330 0,255,220
chr11 69503337 69503922 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 329 . 69503337 69503922 0,255,174
chr11 69514966 69515386 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 418 . 69514966 69515386 0,255,83
chr11 69521520 69521959 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 338 . 69521520 69521959 0,255,165
chr11 69559325 69559614 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 297 . 69559325 69559614 0,255,207
chr11 69643454 69644497 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 470 . 69643454 69644497 0,255,30
chr11 69670931 69671545 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 433 . 69670931 69671545 0,255,68
chr11 69824961 69825311 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 290 . 69824961 69825311 0,255,214
chr11 69880618 69880911 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 351 . 69880618 69880911 0,255,151
chr12 95427 95699 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 514 . 95427 95699 14,255,0
chr12 95446 95485 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 485 . 95446 95485 0,255,15
chr12 95446 95492 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 609 . 95446 95492 111,255,0
chr12 95446 95512 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 583 . 95446 95512 84,255,0
chr12 2365008 2365229 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 691 . 2365008 2365229 194,255,0
chr12 2365039 2365197 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 590 . 2365039 2365197 91,255,0
chr12 2365051 2365195 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 461 . 2365051 2365195 0,255,39
chr12 20704363 20704495 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 20704363 20704495 255,0,0
chr12 34846894 34847004 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 756 . 34846894 34847004 255,248,0
chr12 38164791 38164825 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 552 . 38164791 38164825 53,255,0
chr12 41757456 41757515 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 926 . 41757456 41757515 255,75,0
chr12 41757461 41757509 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 764 . 41757461 41757509 255,240,0
chr12 66451390 66451444 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 458 . 66451390 66451444 0,255,42
chr12 66451391 66451434 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 396 . 66451391 66451434 0,255,106
chr12 66451394 66451443 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 421 . 66451394 66451443 0,255,80
chr12 131130753 131131001 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 974 . 131130753 131131001 255,26,0
chr12 132061429 132061493 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 388 . 132061429 132061493 0,255,114
chr12 133841535 133841869 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 540 . 133841535 133841869 40,255,0
chr12 133841570 133841849 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 537 . 133841570 133841849 37,255,0
chr12 133841585 133841840 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 634 . 133841585 133841840 136,255,0
chr12 133841611 133841815 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 337 . 133841611 133841815 0,255,166
chr12 133841613 133841819 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 401 . 133841613 133841819 0,255,100
chr12 133841629 133841795 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 316 . 133841629 133841795 0,255,187
chr12 133841676 133841715 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 262 . 133841676 133841715 0,255,242
chr12 133841800 133841853 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 281 . 133841800 133841853 0,255,223
chr13 21951487 21951602 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 290 . 21951487 21951602 0,255,214
chr13 110076493 110076677 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 633 . 110076493 110076677 135,255,0
chr13 110076498 110076662 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 471 . 110076498 110076662 0,255,29
chr13 110076586 110076668 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 249 . 110076586 110076668 0,253,255
chr13 111037957 111038241 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 262 . 111037957 111038241 0,255,242
chr14 32954262 32954306 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 517 . 32954262 32954306 17,255,0
chr14 79723729 79723858 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 477 . 79723729 79723858 0,255,23
chr14 100394319 100394536 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 416 . 100394319 100394536 0,255,85
chr14 100394342 100394503 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 385 . 100394342 100394503 0,255,117
chr15 77910886 77910921 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 379 . 77910886 77910921 0,255,123
chr15 77910886 77910933 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 481 . 77910886 77910933 0,255,19
chr15 77910891 77910929 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 382 . 77910891 77910929 0,255,120
chr15 102304152 102304377 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 318 . 102304152 102304377 0,255,185
chr16 544788 545019 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 741 . 544788 545019 245,255,0
chr16 1075325 1075460 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 345 . 1075325 1075460 0,255,158
chr16 1075329 1075446 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 282 . 1075329 1075446 0,255,222
chr16 1075331 1075445 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 340 . 1075331 1075445 0,255,163
chr16 1075344 1075458 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 344 . 1075344 1075458 0,255,159
chr16 14580906 14580954 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 239 . 14580906 14580954 0,243,255
chr16 21552344 21552515 ID=SRX012395;Name=H3K9me1%20(@%20CD4%2B%20T%20cells);Title=GSM417823:%20HS%20CD4%20Act%2018h%20%20H3K9me1;Cell%20group=Blood;
source_name=CD4%2B%20T%20cells;antigen=H3K9me1;antibody=ab8896; 296 . 21552344 21552515 0,255,208
chr16 33293973 33294345 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 322 . 33293973 33294345 0,255,181
chr16 33874019 33874134 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 761 . 33874019 33874134 255,243,0
chr16 33874024 33874134 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 671 . 33874024 33874134 174,255,0
chr16 33887615 33887800 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 33887615 33887800 255,0,0
chr16 33887619 33887778 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 33887619 33887778 255,0,0
chr16 33887631 33887777 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 33887631 33887777 255,0,0
chr16 33887634 33887763 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 934 . 33887634 33887763 255,67,0
chr16 33887635 33887771 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 33887635 33887771 255,0,0
chr16 33887637 33887767 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 33887637 33887767 255,0,0
chr16 33887652 33887733 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 336 . 33887652 33887733 0,255,167
chr16 33899809 33899956 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 887 . 33899809 33899956 255,115,0
chr16 33899812 33899949 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 856 . 33899812 33899949 255,146,0
chr16 34022171 34022309 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 868 . 34022171 34022309 255,134,0
chr16 35239607 35239741 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 35239607 35239741 255,0,0
chr16 35239610 35239739 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 35239610 35239739 255,0,0
chr16 35239617 35239730 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 863 . 35239617 35239730 255,139,0
chr16 35239620 35239731 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 820 . 35239620 35239731 255,183,0
chr16 35239622 35239730 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 737 . 35239622 35239730 241,255,0
chr16 35239627 35239727 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 606 . 35239627 35239727 108,255,0
chr16 35239646 35239692 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 488 . 35239646 35239692 0,255,12
chr16 35239648 35239692 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 419 . 35239648 35239692 0,255,82
chr16 35239654 35239689 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 341 . 35239654 35239689 0,255,162
chr16 35239657 35239693 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 408 . 35239657 35239693 0,255,93
chr16 46386769 46387040 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 430 . 46386769 46387040 0,255,71
chr16 46386886 46387027 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 222 . 46386886 46387027 0,226,255
chr16 46391239 46391582 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 319 . 46391239 46391582 0,255,184
chr16 46391963 46392211 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 299 . 46391963 46392211 0,255,205
chr16 46401875 46402126 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 374 . 46401875 46402126 0,255,128
chr16 46401888 46402120 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 265 . 46401888 46402120 0,255,239
chr16 46405036 46405530 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 368 . 46405036 46405530 0,255,134
chr16 46405139 46405498 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 265 . 46405139 46405498 0,255,239
chr16 46406184 46406997 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 427 . 46406184 46406997 0,255,74
chr16 46406218 46406986 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 308 . 46406218 46406986 0,255,195
chr16 46406746 46406993 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 319 . 46406746 46406993 0,255,184
chr16 46408288 46408566 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 458 . 46408288 46408566 0,255,42
chr16 46408297 46408533 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 339 . 46408297 46408533 0,255,164
chr16 46412843 46413129 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 424 . 46412843 46413129 0,255,77
chr16 46412924 46413429 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46412924 46413429 255,0,0
chr16 46412967 46413387 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 389 . 46412967 46413387 0,255,113
chr16 46412985 46413405 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 815 . 46412985 46413405 255,188,0
chr16 46413010 46413444 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 417 . 46413010 46413444 0,255,84
chr16 46413050 46413359 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 301 . 46413050 46413359 0,255,202
chr16 46416888 46417375 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 407 . 46416888 46417375 0,255,94
chr16 46416932 46417427 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 534 . 46416932 46417427 34,255,0
chr16 46420349 46420476 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 308 . 46420349 46420476 0,255,195
chr16 46420357 46420489 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 276 . 46420357 46420489 0,255,228
chr16 46432476 46432585 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 372 . 46432476 46432585 0,255,130
chr16 46432479 46433213 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46432479 46433213 255,0,0
chr16 46432487 46432987 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 424 . 46432487 46432987 0,255,77
chr16 46432493 46432864 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 438 . 46432493 46432864 0,255,63
chr16 46432497 46433307 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46432497 46433307 255,0,0
chr16 46432676 46432802 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 537 . 46432676 46432802 37,255,0
chr16 46432697 46432817 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 454 . 46432697 46432817 0,255,46
chr16 46433963 46434168 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 416 . 46433963 46434168 0,255,85
chr16 46435230 46435504 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 909 . 46435230 46435504 255,92,0
chr16 46435232 46435521 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46435232 46435521 255,0,0
chr16 46435274 46435512 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 665 . 46435274 46435512 168,255,0
chr16 46435286 46435515 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 729 . 46435286 46435515 233,255,0
chr16 46435297 46435481 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 373 . 46435297 46435481 0,255,129
chr16 46435307 46435492 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 445 . 46435307 46435492 0,255,56
chr16 46435312 46435485 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 338 . 46435312 46435485 0,255,165
chr16 46435313 46435477 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 331 . 46435313 46435477 0,255,172
chr17 22245560 22245674 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 351 . 22245560 22245674 0,255,151
chr17 22245598 22245952 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 757 . 22245598 22245952 255,247,0
chr17 22245630 22245946 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 743 . 22245630 22245946 247,255,0
chr17 22247854 22248157 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 822 . 22247854 22248157 255,181,0
chr17 22247873 22248152 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 732 . 22247873 22248152 236,255,0
chr17 22252937 22253331 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 821 . 22252937 22253331 255,182,0
chr17 22252951 22253323 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 712 . 22252951 22253323 216,255,0
chr17 22253013 22253299 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 509 . 22253013 22253299 9,255,0
chr17 22253116 22253275 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 696 . 22253116 22253275 199,255,0
chr17 22253154 22253276 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 493 . 22253154 22253276 0,255,7
chr17 22253161 22253272 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 382 . 22253161 22253272 0,255,120
chr17 22253162 22253269 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 379 . 22253162 22253269 0,255,123
chr17 22253166 22253285 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 329 . 22253166 22253285 0,255,174
chr17 22253169 22253273 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 383 . 22253169 22253273 0,255,119
chr17 22254672 22255303 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 616 . 22254672 22255303 118,255,0
chr17 22254679 22255332 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 568 . 22254679 22255332 69,255,0
chr17 22258230 22258661 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 423 . 22258230 22258661 0,255,78
chr17 22259694 22260046 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 621 . 22259694 22260046 123,255,0
chr17 22259701 22260023 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 617 . 22259701 22260023 119,255,0
chr17 22260459 22261625 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 22260459 22261625 255,0,0
chr17 22260465 22261639 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 22260465 22261639 255,0,0
chr17 22261133 22261491 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 403 . 22261133 22261491 0,255,98
chr17 22261143 22261614 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 467 . 22261143 22261614 0,255,33
chr17 22261171 22261611 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 346 . 22261171 22261611 0,255,157
chr17 22261556 22261608 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 316 . 22261556 22261608 0,255,187
chr17 25263807 25263941 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 840 . 25263807 25263941 255,163,0
chr17 25263810 25263951 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 998 . 25263810 25263951 255,2,0
chr17 25267772 25267889 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 433 . 25267772 25267889 0,255,68
chr17 41381680 41382422 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 866 . 41381680 41382422 255,136,0
chr17 41381690 41381960 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 267 . 41381690 41381960 0,255,237
chr17 41381698 41382320 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 772 . 41381698 41382320 255,232,0
chr17 41381709 41382258 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 300 . 41381709 41382258 0,255,204
chr17 41381821 41382276 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 349 . 41381821 41382276 0,255,154
chr17 41399877 41401009 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 431 . 41399877 41401009 0,255,70
chr17 41399916 41401132 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 909 . 41399916 41401132 255,92,0
chr17 41400129 41401004 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 412 . 41400129 41401004 0,255,89
chr17 41400210 41400664 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 344 . 41400210 41400664 0,255,159
chr17 41400230 41401153 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 619 . 41400230 41401153 121,255,0
chr17 41400578 41400912 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 285 . 41400578 41400912 0,255,219
chr17 41400599 41401010 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 401 . 41400599 41401010 0,255,100
chr17 41466092 41466382 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 793 . 41466092 41466382 255,211,0
chr17 41466116 41466369 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 528 . 41466116 41466369 28,255,0
chr17 51183690 51183730 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 527 . 51183690 51183730 27,255,0
chr17 64794868 64795353 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 296 . 64794868 64795353 0,255,208
chr18 107903 109252 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 107903 109252 255,0,0
chr18 107913 109254 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 107913 109254 255,0,0
chr18 107960 108472 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 107960 108472 255,0,0
chr18 107968 108503 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 841 . 107968 108503 255,162,0
chr18 107980 108478 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 698 . 107980 108478 201,255,0
chr18 108031 108491 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 500 . 108031 108491 0,255,0
chr18 108088 108253 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 529 . 108088 108253 29,255,0
chr18 108088 108256 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 522 . 108088 108256 22,255,0
chr18 108088 108285 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 895 . 108088 108285 255,107,0
chr18 108091 108250 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 537 . 108091 108250 37,255,0
chr18 108093 108565 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 877 . 108093 108565 255,125,0
chr18 108097 108251 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 522 . 108097 108251 22,255,0
chr18 108108 108407 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 423 . 108108 108407 0,255,78
chr18 108191 108227 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 280 . 108191 108227 0,255,224
chr18 108390 108514 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 553 . 108390 108514 54,255,0
chr18 108407 108512 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 339 . 108407 108512 0,255,164
chr18 108408 108538 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 335 . 108408 108538 0,255,168
chr18 108413 108531 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 358 . 108413 108531 0,255,144
chr18 110231 110707 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 110231 110707 255,0,0
chr18 110236 110658 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 110236 110658 255,0,0
chr18 110280 110403 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 414 . 110280 110403 0,255,87
chr18 110282 110458 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 418 . 110282 110458 0,255,83
chr18 110302 110455 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 288 . 110302 110455 0,255,216
chr18 110308 110457 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 320 . 110308 110457 0,255,183
chr18 110313 110421 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 252 . 110313 110421 0,255,252
chr18 2842276 2842316 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 704 . 2842276 2842316 208,255,0
chr18 2842276 2842319 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 514 . 2842276 2842319 14,255,0
chr18 18512882 18513143 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 898 . 18512882 18513143 255,104,0
chr18 18517157 18517344 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 395 . 18517157 18517344 0,255,107
chr18 18518113 18518147 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 279 . 18518113 18518147 0,255,225
chr18 18518113 18518148 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 304 . 18518113 18518148 0,255,199
chr18 18518114 18518149 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 294 . 18518114 18518149 0,255,210
chr18 18518811 18519660 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 18518811 18519660 255,0,0
chr18 18518812 18519654 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 18518812 18519654 255,0,0
chr18 18518842 18519130 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 651 . 18518842 18519130 154,255,0
chr18 18518850 18519128 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 644 . 18518850 18519128 146,255,0
chr18 18518883 18519116 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 355 . 18518883 18519116 0,255,147
chr18 18518884 18519116 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 351 . 18518884 18519116 0,255,151
chr18 18518885 18519109 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 413 . 18518885 18519109 0,255,88
chr18 18518903 18519112 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 290 . 18518903 18519112 0,255,214
chr18 18519300 18519502 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 495 . 18519300 18519502 0,255,5
chr18 18519309 18519505 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 359 . 18519309 18519505 0,255,143
chr18 18519315 18519486 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 340 . 18519315 18519486 0,255,163
chr18 18519316 18519507 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 359 . 18519316 18519507 0,255,143
chr18 18519874 18519975 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 275 . 18519874 18519975 0,255,229
chr18 18519883 18520022 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 353 . 18519883 18520022 0,255,149
chr18 18519885 18520002 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 316 . 18519885 18520002 0,255,187
chr18 18519887 18520241 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 547 . 18519887 18520241 47,255,0
chr18 18519967 18520212 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 398 . 18519967 18520212 0,255,104
chr18 18520115 18520314 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 712 . 18520115 18520314 216,255,0
chr18 18520123 18520297 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 453 . 18520123 18520297 0,255,47
chr18 18520145 18520280 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 421 . 18520145 18520280 0,255,80
chr18 18520148 18520280 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 378 . 18520148 18520280 0,255,124
chr18 18520149 18520279 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 400 . 18520149 18520279 0,255,102
chr18 18520161 18520275 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 347 . 18520161 18520275 0,255,156
chr18 18520267 18520303 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 334 . 18520267 18520303 0,255,169
chr18 18520268 18520302 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 303 . 18520268 18520302 0,255,200
chr18 45379659 45379702 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 553 . 45379659 45379702 54,255,0
chr18 50319111 50319246 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 50319111 50319246 255,0,0
chr18 50319148 50319198 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 649 . 50319148 50319198 151,255,0
chr18 50319150 50319200 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 612 . 50319150 50319200 114,255,0
chr18 50319150 50319211 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 471 . 50319150 50319211 0,255,29
chr18 50319160 50319201 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 445 . 50319160 50319201 0,255,56
chr18 50319161 50319194 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 395 . 50319161 50319194 0,255,107
chr18 77379847 77380182 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 596 . 77379847 77380182 97,255,0
chr19 7515557 7515978 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 649 . 7515557 7515978 151,255,0
chr19 7515594 7515920 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 440 . 7515594 7515920 0,255,61
chr19 24474664 24474701 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 623 . 24474664 24474701 125,255,0
chr19 24474664 24474702 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 634 . 24474664 24474702 136,255,0
chr19 24474666 24474701 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 568 . 24474666 24474701 69,255,0
chr19 24526174 24526209 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 533 . 24526174 24526209 33,255,0
chr19 24526175 24526209 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 526 . 24526175 24526209 26,255,0
chr19 24526176 24526209 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 507 . 24526176 24526209 7,255,0
chr19 27731909 27732530 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 1000 . 27731909 27732530 255,0,0
chr19 27731910 27732721 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 27731910 27732721 255,0,0
chr19 27731911 27732780 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 27731911 27732780 255,0,0
chr19 27731913 27732715 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 27731913 27732715 255,0,0
chr19 27731914 27732714 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 27731914 27732714 255,0,0
chr19 27731915 27732811 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27731915 27732811 255,0,0
chr19 27731919 27732807 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27731919 27732807 255,0,0
chr19 27731961 27732555 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 656 . 27731961 27732555 159,255,0
chr19 27731963 27732301 ID=SRX205093;Name=H3K9me1%20(@%20A549);Title=GSM1038462:%20H3K9me1-a549-3d-treated%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;treated%20twice%20with=10%20ng/mL%20TNF%20and%202%20ng/mL%20TGF%20for%2048hr%20each;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 609 . 27731963 27732301 111,255,0
chr19 27731970 27732329 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 700 . 27731970 27732329 204,255,0
chr19 27731975 27732302 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 688 . 27731975 27732302 191,255,0
chr19 27731975 27732306 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 764 . 27731975 27732306 255,240,0
chr19 27731976 27732301 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 723 . 27731976 27732301 227,255,0
chr19 27731977 27732290 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 27731977 27732290 255,0,0
chr19 27731977 27732306 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 746 . 27731977 27732306 250,255,0
chr19 27732005 27732095 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 369 . 27732005 27732095 0,255,133
chr19 27732061 27732096 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 280 . 27732061 27732096 0,255,224
chr19 27732062 27732095 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 253 . 27732062 27732095 0,255,251
chr19 27732217 27732264 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 366 . 27732217 27732264 0,255,136
chr19 27732225 27732262 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 263 . 27732225 27732262 0,255,241
chr19 27732621 27732778 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 671 . 27732621 27732778 174,255,0
chr19 27732621 27732782 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 929 . 27732621 27732782 255,72,0
chr19 27732631 27732770 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 532 . 27732631 27732770 32,255,0
chr19 27732632 27732780 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 519 . 27732632 27732780 19,255,0
chr19 27732633 27732771 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 537 . 27732633 27732771 37,255,0
chr19 27732641 27732777 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 449 . 27732641 27732777 0,255,52
chr19 27732715 27732776 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 246 . 27732715 27732776 0,250,255
chr19 27733043 27733395 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27733043 27733395 255,0,0
chr19 27733045 27733391 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27733045 27733391 255,0,0
chr19 27733055 27733329 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 363 . 27733055 27733329 0,255,139
chr19 27733143 27733378 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 583 . 27733143 27733378 84,255,0
chr19 27733150 27733251 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 422 . 27733150 27733251 0,255,79
chr19 27733150 27733262 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 475 . 27733150 27733262 0,255,25
chr19 27733150 27733321 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 455 . 27733150 27733321 0,255,45
chr19 27733151 27733274 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 447 . 27733151 27733274 0,255,54
chr19 27733205 27733248 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 311 . 27733205 27733248 0,255,192
chr19 27733206 27733246 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 223 . 27733206 27733246 0,227,255
chr19 27733206 27733248 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 236 . 27733206 27733248 0,240,255
chr19 27733974 27734612 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27733974 27734612 255,0,0
chr19 27734109 27734585 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27734109 27734585 255,0,0
chr19 27736233 27736587 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27736233 27736587 255,0,0
chr19 27736245 27736566 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 892 . 27736245 27736566 255,110,0
chr19 27736378 27736493 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 476 . 27736378 27736493 0,255,24
chr19 27736381 27736497 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 437 . 27736381 27736497 0,255,64
chr19 27736385 27736488 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 455 . 27736385 27736488 0,255,45
chr19 27736391 27736502 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 461 . 27736391 27736502 0,255,39
chr19 27738312 27738765 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 740 . 27738312 27738765 244,255,0
chr19 27738380 27738747 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 626 . 27738380 27738747 128,255,0
chr19 27738384 27738756 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 584 . 27738384 27738756 85,255,0
chr19 27738394 27738750 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 574 . 27738394 27738750 75,255,0
chr19 27738407 27738659 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27738407 27738659 255,0,0
chr19 27738408 27738668 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27738408 27738668 255,0,0
chr19 27738408 27738724 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 489 . 27738408 27738724 0,255,11
chr19 27738419 27738721 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 436 . 27738419 27738721 0,255,65
chr19 27738422 27738626 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 736 . 27738422 27738626 240,255,0
chr19 27738426 27738605 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 27738426 27738605 255,0,0
chr19 27738431 27738603 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 769 . 27738431 27738603 255,235,0
chr19 27738434 27738599 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 738 . 27738434 27738599 242,255,0
chr19 27738435 27738600 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 726 . 27738435 27738600 230,255,0
chr19 27738438 27738495 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 318 . 27738438 27738495 0,255,185
chr19 27738439 27738604 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 726 . 27738439 27738604 230,255,0
chr19 27764632 27764666 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 421 . 27764632 27764666 0,255,80
chr19 44915577 44915738 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 952 . 44915577 44915738 255,48,0
chr19 44961407 44961515 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 557 . 44961407 44961515 58,255,0
chr19 48459226 48459580 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 48459226 48459580 255,0,0
chr19_gl000208_random 74 380 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 767 . 74 380 255,237,0
chr19_gl000208_random 88 292 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 309 . 88 292 0,255,194
chr19_gl000208_random 90 359 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 778 . 90 359 255,226,0
chr19_gl000208_random 91 259 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 308 . 91 259 0,255,195
chr19_gl000208_random 99 298 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 351 . 99 298 0,255,151
chr19_gl000208_random 89697 90815 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 789 . 89697 90815 255,215,0
chr19_gl000208_random 89709 90330 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 572 . 89709 90330 73,255,0
chr19_gl000208_random 90554 90780 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 521 . 90554 90780 21,255,0
chr19_gl000208_random 91242 91754 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 468 . 91242 91754 0,255,32
chr19_gl000208_random 91290 91819 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 413 . 91290 91819 0,255,88
chr19_gl000208_random 92184 92482 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 363 . 92184 92482 0,255,139
chr2 33091973 33092015 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 338 . 33091973 33092015 0,255,165
chr2 33141109 33141606 ID=SRX205093;Name=H3K9me1%20(@%20A549);Title=GSM1038462:%20H3K9me1-a549-3d-treated%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;treated%20twice%20with=10%20ng/mL%20TNF%20and%202%20ng/mL%20TGF%20for%2048hr%20each;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 981 . 33141109 33141606 255,19,0
chr2 33141173 33141633 ID=SRX005150;Name=H3K9me1%20(@%20Hematopoietic%20Stem%20Cells);Title=NA;Cell%20group=Blood;
cell%20type=CD133%2B%20primary%20hematopoietic%20stem%20cells/progenitor%20cells%20(HSCs/HPCs)cells;chip%20antibody=H3K9me1; 1000 . 33141173 33141633 255,0,0
chr2 33141223 33141653 ID=SRX005160;Name=H3K9me1%20(@%20CD36%2B);Title=NA;Cell%20group=Blood;
cell%20type=CD36%2B%20primary%20hematopoietic%20stem%20cells/progenitor%20cells%20(HSCs/HPCs)cells;chip%20antibody=H3K9me1; 1000 . 33141223 33141653 255,0,0
chr2 33141231 33141643 ID=SRX012395;Name=H3K9me1%20(@%20CD4%2B%20T%20cells);Title=GSM417823:%20HS%20CD4%20Act%2018h%20%20H3K9me1;Cell%20group=Blood;
source_name=CD4%2B%20T%20cells;antigen=H3K9me1;antibody=ab8896; 844 . 33141231 33141643 255,159,0
chr2 33141299 33141698 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 33141299 33141698 255,0,0
chr2 33141300 33141689 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 956 . 33141300 33141689 255,44,0
chr2 33141309 33141671 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 458 . 33141309 33141671 0,255,42
chr2 33141311 33141667 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 447 . 33141311 33141667 0,255,54
chr2 33141313 33141392 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 355 . 33141313 33141392 0,255,147
chr2 33141313 33141654 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 33141313 33141654 255,0,0
chr2 33141318 33141655 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 823 . 33141318 33141655 255,180,0
chr2 33141318 33141658 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 33141318 33141658 255,0,0
chr2 33141320 33141656 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 809 . 33141320 33141656 255,194,0
chr2 33141324 33141386 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 537 . 33141324 33141386 37,255,0
chr2 33141430 33141665 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 425 . 33141430 33141665 0,255,76
chr2 33141435 33141502 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 278 . 33141435 33141502 0,255,226
chr2 33141446 33141664 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 570 . 33141446 33141664 71,255,0
chr2 33141565 33141616 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 503 . 33141565 33141616 3,255,0
chr2 49456917 49456952 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 546 . 49456917 49456952 46,255,0
chr2 87623793 87623908 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 322 . 87623793 87623908 0,255,181
chr2 87623803 87623920 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 361 . 87623803 87623920 0,255,141
chr2 87623806 87623918 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 378 . 87623806 87623918 0,255,124
chr2 87623827 87623949 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 348 . 87623827 87623949 0,255,155
chr2 87641866 87642167 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 87641866 87642167 255,0,0
chr2 87641946 87642102 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 367 . 87641946 87642102 0,255,135
chr2 88124426 88124485 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 633 . 88124426 88124485 135,255,0
chr2 89853179 89853294 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 637 . 89853179 89853294 139,255,0
chr2 89869765 89869887 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 518 . 89869765 89869887 18,255,0
chr2 89869769 89869904 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 544 . 89869769 89869904 44,255,0
chr2 89877418 89877543 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 536 . 89877418 89877543 36,255,0
chr2 89877431 89877547 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 622 . 89877431 89877547 124,255,0
chr2 89878470 89878517 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 330 . 89878470 89878517 0,255,173
chr2 89879110 89879167 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 481 . 89879110 89879167 0,255,19
chr2 89879115 89879168 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 340 . 89879115 89879168 0,255,163
chr2 89879116 89879152 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 314 . 89879116 89879152 0,255,189
chr2 89879116 89879164 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 291 . 89879116 89879164 0,255,213
chr2 89879117 89879166 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 270 . 89879117 89879166 0,255,234
chr2 89879119 89879158 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 279 . 89879119 89879158 0,255,225
chr2 89879843 89879969 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 606 . 89879843 89879969 108,255,0
chr2 89879852 89879960 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 611 . 89879852 89879960 113,255,0
chr2 89879852 89879966 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 605 . 89879852 89879966 107,255,0
chr2 90383282 90383497 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 359 . 90383282 90383497 0,255,143
chr2 90451081 90451200 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 268 . 90451081 90451200 0,255,236
chr2 90481742 90482303 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 435 . 90481742 90482303 0,255,66
chr2 91604777 91604991 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 355 . 91604777 91604991 0,255,147
chr2 92269062 92269723 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 880 . 92269062 92269723 255,122,0
chr2 92269080 92269649 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 473 . 92269080 92269649 0,255,27
chr2 92269127 92269724 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92269127 92269724 255,0,0
chr2 92269157 92269710 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92269157 92269710 255,0,0
chr2 92269310 92269626 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 517 . 92269310 92269626 17,255,0
chr2 92269318 92269741 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 661 . 92269318 92269741 164,255,0
chr2 92269441 92269559 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 798 . 92269441 92269559 255,206,0
chr2 92269442 92269567 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 843 . 92269442 92269567 255,160,0
chr2 92269443 92269572 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 722 . 92269443 92269572 226,255,0
chr2 92269443 92269783 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 593 . 92269443 92269783 94,255,0
chr2 92269444 92269573 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 787 . 92269444 92269573 255,217,0
chr2 92269446 92269587 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 759 . 92269446 92269587 255,245,0
chr2 92281261 92281556 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 730 . 92281261 92281556 234,255,0
chr2 92281263 92281550 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 720 . 92281263 92281550 224,255,0
chr2 92281291 92281327 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 454 . 92281291 92281327 0,255,46
chr2 92281292 92281330 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 453 . 92281292 92281330 0,255,47
chr2 92281293 92281328 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 432 . 92281293 92281328 0,255,69
chr2 92281293 92281329 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 397 . 92281293 92281329 0,255,105
chr2 92290424 92291589 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 839 . 92290424 92291589 255,164,0
chr2 92290516 92291625 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92290516 92291625 255,0,0
chr2 92290521 92291624 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92290521 92291624 255,0,0
chr2 92290529 92291182 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 634 . 92290529 92291182 136,255,0
chr2 92290602 92290762 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 689 . 92290602 92290762 192,255,0
chr2 92290605 92290756 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 860 . 92290605 92290756 255,142,0
chr2 92290605 92291584 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 637 . 92290605 92291584 139,255,0
chr2 92290607 92290751 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 921 . 92290607 92290751 255,80,0
chr2 92290608 92290754 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 797 . 92290608 92290754 255,207,0
chr2 92290610 92290758 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 808 . 92290610 92290758 255,195,0
chr2 92290616 92290754 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 801 . 92290616 92290754 255,202,0
chr2 92290656 92291174 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 505 . 92290656 92291174 5,255,0
chr2 92290804 92291235 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 408 . 92290804 92291235 0,255,93
chr2 92290895 92291180 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 747 . 92290895 92291180 251,255,0
chr2 92290903 92291169 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 709 . 92290903 92291169 213,255,0
chr2 92290913 92291148 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 602 . 92290913 92291148 104,255,0
chr2 92290913 92291151 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 601 . 92290913 92291151 103,255,0
chr2 92290914 92291151 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 509 . 92290914 92291151 9,255,0
chr2 92290917 92291157 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 544 . 92290917 92291157 44,255,0
chr2 92291259 92291589 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 527 . 92291259 92291589 27,255,0
chr2 92291277 92291572 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 400 . 92291277 92291572 0,255,102
chr2 92291408 92291598 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 986 . 92291408 92291598 255,14,0
chr2 92291416 92291585 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 878 . 92291416 92291585 255,124,0
chr2 92291428 92291574 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 724 . 92291428 92291574 228,255,0
chr2 92291430 92291581 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 703 . 92291430 92291581 207,255,0
chr2 92291432 92291576 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 699 . 92291432 92291576 202,255,0
chr2 92291435 92291581 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 746 . 92291435 92291581 250,255,0
chr2 92296225 92297114 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92296225 92297114 255,0,0
chr2 92296586 92297185 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92296586 92297185 255,0,0
chr2 92296772 92297119 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 394 . 92296772 92297119 0,255,108
chr2 92296809 92297102 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 383 . 92296809 92297102 0,255,119
chr2 92296852 92296894 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 264 . 92296852 92296894 0,255,240
chr2 92297321 92297602 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 712 . 92297321 92297602 216,255,0
chr2 92297355 92297581 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 726 . 92297355 92297581 230,255,0
chr2 92297856 92298121 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 803 . 92297856 92298121 255,200,0
chr2 92297880 92298131 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 958 . 92297880 92298131 255,42,0
chr2 92297961 92298110 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 307 . 92297961 92298110 0,255,196
chr2 92305662 92305789 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 440 . 92305662 92305789 0,255,61
chr2 92307088 92307520 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92307088 92307520 255,0,0
chr2 92307119 92307508 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92307119 92307508 255,0,0
chr2 92307193 92307484 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 524 . 92307193 92307484 24,255,0
chr2 92307299 92307443 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 526 . 92307299 92307443 26,255,0
chr2 92307302 92307432 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 427 . 92307302 92307432 0,255,74
chr2 92307302 92307441 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 413 . 92307302 92307441 0,255,88
chr2 92307310 92307433 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 371 . 92307310 92307433 0,255,131
chr2 92307311 92307420 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 343 . 92307311 92307420 0,255,160
chr2 92307330 92307448 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 448 . 92307330 92307448 0,255,53
chr2 92312967 92313472 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 537 . 92312967 92313472 37,255,0
chr2 92318697 92319402 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 619 . 92318697 92319402 121,255,0
chr2 92318809 92319359 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 429 . 92318809 92319359 0,255,72
chr2 92319905 92320661 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 383 . 92319905 92320661 0,255,119
chr2 92320352 92320654 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 340 . 92320352 92320654 0,255,163
chr2 92324336 92324611 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 652 . 92324336 92324611 155,255,0
chr2 92324381 92324652 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 660 . 92324381 92324652 163,255,0
chr2 92324843 92325896 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 999 . 92324843 92325896 255,1,0
chr2 92324855 92325339 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92324855 92325339 255,0,0
chr2 92324965 92325338 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 580 . 92324965 92325338 81,255,0
chr2 92324965 92325349 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 594 . 92324965 92325349 95,255,0
chr2 92324973 92325335 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 489 . 92324973 92325335 0,255,11
chr2 92325051 92325227 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 438 . 92325051 92325227 0,255,63
chr2 92325059 92325254 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 337 . 92325059 92325254 0,255,166
chr2 92325061 92325252 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 320 . 92325061 92325252 0,255,183
chr2 92325063 92325277 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 351 . 92325063 92325277 0,255,151
chr2 92325066 92325254 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 350 . 92325066 92325254 0,255,153
chr2 92325067 92325287 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 430 . 92325067 92325287 0,255,71
chr2 109815793 109816303 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 109815793 109816303 255,0,0
chr2 109815796 109816295 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 109815796 109816295 255,0,0
chr2 109815822 109816267 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 718 . 109815822 109816267 222,255,0
chr2 109815842 109816257 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 672 . 109815842 109816257 175,255,0
chr2 109815844 109816262 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 509 . 109815844 109816262 9,255,0
chr2 109815847 109816256 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 546 . 109815847 109816256 46,255,0
chr2 149639345 149639399 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 602 . 149639345 149639399 104,255,0
chr2 149639347 149639403 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 574 . 149639347 149639403 75,255,0
chr2 162136725 162136841 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 345 . 162136725 162136841 0,255,158
chr2 162137716 162137833 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 517 . 162137716 162137833 17,255,0
chr2 162138212 162138434 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 550 . 162138212 162138434 51,255,0
chr2 162138799 162139031 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 454 . 162138799 162139031 0,255,46
chr20 26305697 26305806 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 670 . 26305697 26305806 173,255,0
chr20 26318016 26318132 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 691 . 26318016 26318132 194,255,0
chr20 26318023 26318125 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 613 . 26318023 26318125 115,255,0
chr20 26318423 26318560 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 860 . 26318423 26318560 255,142,0
chr20 26318427 26318575 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 26318427 26318575 255,0,0
chr20 26318433 26318549 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 634 . 26318433 26318549 136,255,0
chr20 26318435 26318554 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 733 . 26318435 26318554 237,255,0
chr20 26318449 26318559 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 695 . 26318449 26318559 198,255,0
chr20 29653376 29653486 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 250 . 29653376 29653486 0,255,255
chr20 29811923 29812034 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 626 . 29811923 29812034 128,255,0
chr20 29822954 29823073 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 713 . 29822954 29823073 217,255,0
chr20 29829348 29829764 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 29829348 29829764 255,0,0
chr20 29829351 29829764 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 29829351 29829764 255,0,0
chr20 29829379 29829731 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 877 . 29829379 29829731 255,125,0
chr20 29829387 29829741 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 884 . 29829387 29829741 255,118,0
chr20 29829394 29829725 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 631 . 29829394 29829725 133,255,0
chr20 29829402 29829724 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 548 . 29829402 29829724 48,255,0
chr20 29829415 29829708 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 497 . 29829415 29829708 0,255,3
chr20 46523535 46523669 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 513 . 46523535 46523669 13,255,0
chr20 47131753 47131940 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 340 . 47131753 47131940 0,255,163
chr20 47132064 47132342 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 398 . 47132064 47132342 0,255,104
chr20 47132078 47132261 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 325 . 47132078 47132261 0,255,178
chr20 47132126 47132285 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 434 . 47132126 47132285 0,255,67
chr21 9699525 9699651 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 564 . 9699525 9699651 65,255,0
chr21 9826970 9827244 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 653 . 9826970 9827244 156,255,0
chr21 9826991 9827236 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 865 . 9826991 9827236 255,137,0
chr21 9827009 9827257 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 551 . 9827009 9827257 52,255,0
chr21 9827011 9827547 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 9827011 9827547 255,0,0
chr21 10492904 10492950 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 581 . 10492904 10492950 82,255,0
chr21 10807083 10807230 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 845 . 10807083 10807230 255,158,0
chr21 10807088 10807231 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 736 . 10807088 10807231 240,255,0
chr21 10819364 10819744 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 10819364 10819744 255,0,0
chr21 10819367 10819746 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 10819367 10819746 255,0,0
chr21 10819396 10819723 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 10819396 10819723 255,0,0
chr21 10819408 10819703 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 10819408 10819703 255,0,0
chr21 10819408 10819842 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 706 . 10819408 10819842 210,255,0
chr21 10819416 10819708 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 992 . 10819416 10819708 255,8,0
chr21 10819422 10819717 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 10819422 10819717 255,0,0
chr21 10819562 10819634 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 566 . 10819562 10819634 67,255,0
chr21 10819565 10819602 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 440 . 10819565 10819602 0,255,61
chr21 10839120 10839230 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 643 . 10839120 10839230 145,255,0
chr21 10853642 10853751 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 620 . 10853642 10853751 122,255,0
chr21 10856796 10856921 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 988 . 10856796 10856921 255,12,0
chr21 10856803 10856916 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 672 . 10856803 10856916 175,255,0
chr21 10856830 10856882 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 711 . 10856830 10856882 215,255,0
chr21 10856842 10856878 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 527 . 10856842 10856878 27,255,0
chr21 10856843 10856878 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 543 . 10856843 10856878 43,255,0
chr21 11186436 11186863 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 11186436 11186863 255,0,0
chr21 11186455 11186867 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 815 . 11186455 11186867 255,188,0
chr21 11186478 11186700 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 11186478 11186700 255,0,0
chr21 11186488 11186808 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 583 . 11186488 11186808 84,255,0
chr21 11186559 11186695 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 902 . 11186559 11186695 255,99,0
chr21 11186567 11186696 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 840 . 11186567 11186696 255,163,0
chr21 11186574 11186689 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 647 . 11186574 11186689 149,255,0
chr21 11186581 11186682 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 579 . 11186581 11186682 80,255,0
chr21 11186590 11186643 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 877 . 11186590 11186643 255,125,0
chr21 11186592 11186641 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 757 . 11186592 11186641 255,247,0
chr21 11186600 11186640 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 670 . 11186600 11186640 173,255,0
chr21 14365307 14365341 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 521 . 14365307 14365341 21,255,0
chr21 33157129 33157318 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 313 . 33157129 33157318 0,255,190
chr21 48119807 48119841 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 356 . 48119807 48119841 0,255,146
chr22 18688303 18688443 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 18688303 18688443 255,0,0
chr22 18688306 18688433 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 826 . 18688306 18688433 255,177,0
chr22 18688312 18688430 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 590 . 18688312 18688430 91,255,0
chr22 18688324 18688436 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 707 . 18688324 18688436 211,255,0
chr22 18688343 18688629 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 348 . 18688343 18688629 0,255,155
chr22 18688349 18688391 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 738 . 18688349 18688391 242,255,0
chr22 18688351 18688392 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 699 . 18688351 18688392 202,255,0
chr22 18688354 18688390 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 574 . 18688354 18688390 75,255,0
chr22 18717948 18718222 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 18717948 18718222 255,0,0
chr22 18718024 18718179 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 662 . 18718024 18718179 165,255,0
chr22 18718039 18718182 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 632 . 18718039 18718182 134,255,0
chr22 18718057 18718185 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 546 . 18718057 18718185 46,255,0
chr22 18718059 18718194 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 678 . 18718059 18718194 181,255,0
chr22 18718062 18718177 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 421 . 18718062 18718177 0,255,80
chr22 18878268 18878302 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 428 . 18878268 18878302 0,255,73
chr22 18879948 18880068 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 931 . 18879948 18880068 255,70,0
chr22 18879951 18880069 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 833 . 18879951 18880069 255,170,0
chr22 18879983 18880034 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 723 . 18879983 18880034 227,255,0
chr22 18879987 18880029 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 666 . 18879987 18880029 169,255,0
chr22 18879990 18880024 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 535 . 18879990 18880024 35,255,0
chr22 18879992 18880027 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 511 . 18879992 18880027 11,255,0
chr22 18883719 18884112 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 724 . 18883719 18884112 228,255,0
chr22 18883740 18883857 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 425 . 18883740 18883857 0,255,76
chr22 18883768 18884135 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 696 . 18883768 18884135 199,255,0
chr22 18883776 18884080 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 419 . 18883776 18884080 0,255,82
chr22 18883776 18884080 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 18883776 18884080 255,0,0
chr22 18883780 18884059 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 655 . 18883780 18884059 158,255,0
chr22 18883916 18884082 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 18883916 18884082 255,0,0
chr22 18883922 18884079 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 18883922 18884079 255,0,0
chr22 18883927 18884073 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 918 . 18883927 18884073 255,83,0
chr22 18883931 18884065 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 679 . 18883931 18884065 182,255,0
chr22 20325855 20326340 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 479 . 20325855 20326340 0,255,21
chr22 20325857 20326301 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 580 . 20325857 20326301 81,255,0
chr22 20656330 20656457 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 959 . 20656330 20656457 255,41,0
chr22 20689437 20689554 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 591 . 20689437 20689554 92,255,0
chr22 21679615 21679744 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 914 . 21679615 21679744 255,87,0
chr22 21680461 21680591 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 998 . 21680461 21680591 255,2,0
chr22 23827868 23827905 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 599 . 23827868 23827905 100,255,0
chr22 23827869 23827903 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 557 . 23827869 23827903 58,255,0
chr22 23828961 23828997 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 538 . 23828961 23828997 38,255,0
chr22 29516157 29516339 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 335 . 29516157 29516339 0,255,168
chr22 29516171 29516345 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 396 . 29516171 29516345 0,255,106
chr22 51082107 51082408 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 591 . 51082107 51082408 92,255,0
chr3 73159996 73160110 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 399 . 73159996 73160110 0,255,103
chr3 75718229 75718601 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 75718229 75718601 255,0,0
chr3 75718243 75718575 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 736 . 75718243 75718575 240,255,0
chr3 75718328 75718508 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 770 . 75718328 75718508 255,234,0
chr3 75718332 75718497 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 521 . 75718332 75718497 21,255,0
chr3 75718370 75718490 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 447 . 75718370 75718490 0,255,54
chr3 75718372 75718480 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 343 . 75718372 75718480 0,255,160
chr3 90477701 90477735 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 503 . 90477701 90477735 3,255,0
chr3 96336767 96336826 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 397 . 96336767 96336826 0,255,105
chr3 96336768 96336817 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 443 . 96336768 96336817 0,255,58
chr3 196625452 196625965 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 952 . 196625452 196625965 255,48,0
chr3 196625482 196625941 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 196625482 196625941 255,0,0
chr3 196625609 196625925 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 826 . 196625609 196625925 255,177,0
chr3 196625610 196625784 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 196625610 196625784 255,0,0
chr3 196625613 196625777 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 196625613 196625777 255,0,0
chr3 196625615 196625929 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 855 . 196625615 196625929 255,147,0
chr3 196625627 196625765 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 804 . 196625627 196625765 255,199,0
chr3 196625632 196625765 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 854 . 196625632 196625765 255,148,0
chr3 196625632 196625765 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 865 . 196625632 196625765 255,137,0
chr3 196625633 196625766 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 196625633 196625766 255,0,0
chr3 196625633 196625769 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 196625633 196625769 255,0,0
chr3 196625634 196625766 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 877 . 196625634 196625766 255,125,0
chr3 196625636 196625764 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 196625636 196625764 255,0,0
chr3 196625638 196625765 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 870 . 196625638 196625765 255,132,0
chr3 196625639 196625764 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 196625639 196625764 255,0,0
chr3 196625664 196625765 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 1000 . 196625664 196625765 255,0,0
chr3 197181872 197181987 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 376 . 197181872 197181987 0,255,126
chr4 9218240 9218716 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 389 . 9218240 9218716 0,255,113
chr4 9218268 9218608 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 275 . 9218268 9218608 0,255,229
chr4 9273534 9274179 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 501 . 9273534 9274179 1,255,0
chr4 9273541 9274131 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 390 . 9273541 9274131 0,255,112
chr4 19079476 19079527 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 736 . 19079476 19079527 240,255,0
chr4 19079477 19079525 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 617 . 19079477 19079525 119,255,0
chr4 19079478 19079520 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 577 . 19079478 19079520 78,255,0
chr4 49103524 49103886 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 361 . 49103524 49103886 0,255,141
chr4 49110293 49110461 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 580 . 49110293 49110461 81,255,0
chr4 49120902 49121032 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 432 . 49120902 49121032 0,255,69
chr4 49120911 49121049 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 593 . 49120911 49121049 94,255,0
chr4 49122079 49122315 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 602 . 49122079 49122315 104,255,0
chr4 49122963 49123136 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 288 . 49122963 49123136 0,255,216
chr4 49141701 49141809 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 481 . 49141701 49141809 0,255,19
chr4 49149326 49149461 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 678 . 49149326 49149461 181,255,0
chr4 49149329 49149453 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 532 . 49149329 49149453 32,255,0
chr4 49151221 49151730 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 570 . 49151221 49151730 71,255,0
chr4 49151354 49151710 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 432 . 49151354 49151710 0,255,69
chr4 49151381 49151516 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 630 . 49151381 49151516 132,255,0
chr4 49151384 49151769 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 449 . 49151384 49151769 0,255,52
chr4 49151386 49151519 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 587 . 49151386 49151519 88,255,0
chr4 49151406 49151705 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 369 . 49151406 49151705 0,255,133
chr4 49151406 49151709 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 372 . 49151406 49151709 0,255,130
chr4 49156446 49156606 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 719 . 49156446 49156606 223,255,0
chr4 49156455 49156605 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 637 . 49156455 49156605 139,255,0
chr4 49156457 49156588 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 475 . 49156457 49156588 0,255,25
chr4 49156470 49156574 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 352 . 49156470 49156574 0,255,150
chr4 49156471 49156576 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 362 . 49156471 49156576 0,255,140
chr4 49318799 49319033 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 847 . 49318799 49319033 255,156,0
chr4 49318830 49319002 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 745 . 49318830 49319002 249,255,0
chr4 49516846 49516976 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 876 . 49516846 49516976 255,126,0
chr4 49636222 49636376 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 273 . 49636222 49636376 0,255,231
chr4 49636224 49636336 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 274 . 49636224 49636336 0,255,230
chr4 49636271 49636386 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 368 . 49636271 49636386 0,255,134
chr4 49637185 49637287 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 567 . 49637185 49637287 68,255,0
chr4 49637187 49637287 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 591 . 49637187 49637287 92,255,0
chr4 49653398 49653517 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 680 . 49653398 49653517 183,255,0
chr4 49653400 49653533 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 788 . 49653400 49653533 255,216,0
chr4 49653412 49653532 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 713 . 49653412 49653532 217,255,0
chr4 49653416 49653531 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 714 . 49653416 49653531 218,255,0
chr4 49653422 49653531 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 691 . 49653422 49653531 194,255,0
chr4 49653423 49653532 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 588 . 49653423 49653532 89,255,0
chr4 49659536 49659753 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 49659536 49659753 255,0,0
chr4 49659548 49659730 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 891 . 49659548 49659730 255,111,0
chr4 49659552 49659734 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 867 . 49659552 49659734 255,135,0
chr4 49659554 49659710 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 814 . 49659554 49659710 255,189,0
chr4 49659556 49659726 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 810 . 49659556 49659726 255,193,0
chr4 49659569 49659727 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 763 . 49659569 49659727 255,241,0
chr4 68264562 68264897 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 448 . 68264562 68264897 0,255,53
chr4 68264660 68264921 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 796 . 68264660 68264921 255,208,0
chr4 68264668 68264928 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 990 . 68264668 68264928 255,10,0
chr4 68264720 68264880 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 861 . 68264720 68264880 255,141,0
chr4 68264738 68264882 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 761 . 68264738 68264882 255,243,0
chr4 68264741 68264881 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 685 . 68264741 68264881 188,255,0
chr4 68264745 68264882 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 679 . 68264745 68264882 182,255,0
chr4 68264752 68264882 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 684 . 68264752 68264882 187,255,0
chr4 68265253 68265597 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 422 . 68265253 68265597 0,255,79
chr4 68265436 68265671 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 822 . 68265436 68265671 255,181,0
chr4 68265436 68265925 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 68265436 68265925 255,0,0
chr4 68265438 68265926 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 68265438 68265926 255,0,0
chr4 68265446 68265666 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 844 . 68265446 68265666 255,159,0
chr4 68265447 68265662 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 767 . 68265447 68265662 255,237,0
chr4 68265450 68265663 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 838 . 68265450 68265663 255,165,0
chr4 68265456 68265658 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 791 . 68265456 68265658 255,213,0
chr4 68265503 68265666 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 869 . 68265503 68265666 255,133,0
chr4 68265564 68265861 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 319 . 68265564 68265861 0,255,184
chr4 68265564 68265861 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 352 . 68265564 68265861 0,255,150
chr4 68265574 68265610 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 405 . 68265574 68265610 0,255,96
chr4 82515399 82515433 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 496 . 82515399 82515433 0,255,4
chr4 182161846 182162070 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 286 . 182161846 182162070 0,255,218
chr4 190155108 190155163 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 397 . 190155108 190155163 0,255,105
chr4 190943547 190943760 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 545 . 190943547 190943760 45,255,0
chr4 190943568 190943751 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 909 . 190943568 190943751 255,92,0
chr4 190943597 190943728 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 476 . 190943597 190943728 0,255,24
chr4 190943599 190943730 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 483 . 190943599 190943730 0,255,17
chr4 190943600 190943728 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 450 . 190943600 190943728 0,255,51
chr5 10188 11373 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 401 . 10188 11373 0,255,100
chr5 10213 10575 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 323 . 10213 10575 0,255,180
chr5 10641 10794 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 228 . 10641 10794 0,232,255
chr5 10852 10953 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 219 . 10852 10953 0,223,255
chr5 17585199 17585600 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 316 . 17585199 17585600 0,255,187
chr5 17599060 17599355 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 587 . 17599060 17599355 88,255,0
chr5 17599095 17599351 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 375 . 17599095 17599351 0,255,127
chr5 49410145 49410390 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 646 . 49410145 49410390 148,255,0
chr5 49410148 49410386 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 713 . 49410148 49410386 217,255,0
chr5 49440623 49441016 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 49440623 49441016 255,0,0
chr5 49440634 49441042 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 49440634 49441042 255,0,0
chr5 49440723 49440887 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 246 . 49440723 49440887 0,250,255
chr5 49440740 49440854 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 271 . 49440740 49440854 0,255,233
chr5 49440746 49440872 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 271 . 49440746 49440872 0,255,233
chr5 71146764 71146873 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 563 . 71146764 71146873 64,255,0
chr5 79947024 79947059 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 362 . 79947024 79947059 0,255,140
chr5 79947274 79947383 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 480 . 79947274 79947383 0,255,20
chr5 79947294 79947370 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 300 . 79947294 79947370 0,255,204
chr5 93905179 93905228 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 819 . 93905179 93905228 255,184,0
chr5 93905183 93905227 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 567 . 93905183 93905227 68,255,0
chr5 134260234 134260290 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 551 . 134260234 134260290 52,255,0
chr5 134260241 134260287 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 450 . 134260241 134260287 0,255,51
chr5 134263431 134263468 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 311 . 134263431 134263468 0,255,192
chr5 177388852 177389086 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 482 . 177388852 177389086 0,255,18
chr5 178012522 178012759 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 852 . 178012522 178012759 255,150,0
chr5 178012579 178012719 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 631 . 178012579 178012719 133,255,0
chr5 178012599 178012701 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 415 . 178012599 178012701 0,255,86
chr5 180473044 180473145 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 342 . 180473044 180473145 0,255,161
chr6 19771143 19771179 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 575 . 19771143 19771179 76,255,0
chr6 58776268 58776813 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 572 . 58776268 58776813 73,255,0
chr6 58776282 58777896 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 340 . 58776282 58777896 0,255,163
chr6 58776328 58779444 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 832 . 58776328 58779444 255,171,0
chr6 58776346 58779439 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 968 . 58776346 58779439 255,32,0
chr6 58776422 58779323 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 757 . 58776422 58779323 255,247,0
chr6 58776433 58779305 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 708 . 58776433 58779305 212,255,0
chr6 58776450 58779300 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 573 . 58776450 58779300 74,255,0
chr6 58776459 58779292 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 540 . 58776459 58779292 40,255,0
chr6 58776617 58777276 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 364 . 58776617 58777276 0,255,138
chr6 58776769 58776998 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 263 . 58776769 58776998 0,255,241
chr6 58776791 58777026 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 212 . 58776791 58777026 0,216,255
chr6 58776960 58777322 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 299 . 58776960 58777322 0,255,205
chr6 58777330 58777915 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 459 . 58777330 58777915 0,255,41
chr6 58777608 58778715 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 354 . 58777608 58778715 0,255,148
chr6 58777649 58777855 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 233 . 58777649 58777855 0,237,255
chr6 58777963 58779289 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 407 . 58777963 58779289 0,255,94
chr6 58777978 58779266 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 342 . 58777978 58779266 0,255,161
chr6 58778127 58778334 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 224 . 58778127 58778334 0,228,255
chr6 58778473 58779309 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 659 . 58778473 58779309 162,255,0
chr6 58778503 58779023 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 256 . 58778503 58779023 0,255,248
chr6 58778788 58779191 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 313 . 58778788 58779191 0,255,190
chr6 61913371 61913525 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 61913371 61913525 255,0,0
chr6 61913376 61913514 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 840 . 61913376 61913514 255,163,0
chr6 61913383 61913510 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 878 . 61913383 61913510 255,124,0
chr6 61913384 61913498 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 785 . 61913384 61913498 255,219,0
chr6 61913385 61913502 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 798 . 61913385 61913502 255,206,0
chr6 61913385 61913510 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 859 . 61913385 61913510 255,143,0
chr6 61913394 61913468 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 361 . 61913394 61913468 0,255,141
chr6 61913398 61913472 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 399 . 61913398 61913472 0,255,103
chr6 61914038 61914322 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 467 . 61914038 61914322 0,255,33
chr6 61914116 61914377 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 884 . 61914116 61914377 255,118,0
chr6 61914140 61914175 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 532 . 61914140 61914175 32,255,0
chr6 61914141 61914175 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 480 . 61914141 61914175 0,255,20
chr6 61914180 61914370 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 608 . 61914180 61914370 110,255,0
chr6 61914182 61914371 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 625 . 61914182 61914371 127,255,0
chr6 61914212 61914366 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 485 . 61914212 61914366 0,255,15
chr6 61914244 61914370 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 570 . 61914244 61914370 71,255,0
chr6 61914248 61914358 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 492 . 61914248 61914358 0,255,8
chr6 61914278 61914321 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 319 . 61914278 61914321 0,255,184
chr6 61914285 61914322 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 350 . 61914285 61914322 0,255,153
chr6 62284064 62284101 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 445 . 62284064 62284101 0,255,56
chr6 157731563 157732010 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 769 . 157731563 157732010 255,235,0
chr6 157731585 157731988 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 541 . 157731585 157731988 41,255,0
chr6 160521775 160521821 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 433 . 160521775 160521821 0,255,68
chr7 20325 20451 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 602 . 20325 20451 104,255,0
chr7 24064 24418 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 788 . 24064 24418 255,216,0
chr7 24075 24394 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 488 . 24075 24394 0,255,12
chr7 945206 945362 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 388 . 945206 945362 0,255,114
chr7 1312084 1312316 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 279 . 1312084 1312316 0,255,225
chr7 45291609 45291652 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 510 . 45291609 45291652 10,255,0
chr7 56439095 56439548 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 634 . 56439095 56439548 136,255,0
chr7 56439139 56439496 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 326 . 56439139 56439496 0,255,177
chr7 56440421 56440653 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 445 . 56440421 56440653 0,255,56
chr7 61055755 61055806 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 748 . 61055755 61055806 252,255,0
chr7 61055756 61055808 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 652 . 61055756 61055808 155,255,0
chr7 61055758 61055802 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 570 . 61055758 61055802 71,255,0
chr7 61055759 61055794 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 533 . 61055759 61055794 33,255,0
chr7 61055761 61055800 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 532 . 61055761 61055800 32,255,0
chr7 61079636 61079750 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 669 . 61079636 61079750 172,255,0
chr7 61079645 61079754 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 603 . 61079645 61079754 105,255,0
chr7 61079649 61079749 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 541 . 61079649 61079749 41,255,0
chr7 61646843 61646952 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 602 . 61646843 61646952 104,255,0
chr7 61968596 61969760 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61968596 61969760 255,0,0
chr7 61968616 61969806 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61968616 61969806 255,0,0
chr7 61968656 61969701 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 61968656 61969701 255,0,0
chr7 61968666 61969698 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 61968666 61969698 255,0,0
chr7 61968685 61969682 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 61968685 61969682 255,0,0
chr7 61968688 61969695 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 61968688 61969695 255,0,0
chr7 61968691 61969666 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 1000 . 61968691 61969666 255,0,0
chr7 61968691 61969700 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 1000 . 61968691 61969700 255,0,0
chr7 61968730 61969651 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 660 . 61968730 61969651 163,255,0
chr7 61968760 61969624 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 680 . 61968760 61969624 183,255,0
chr7 61968761 61969625 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 708 . 61968761 61969625 212,255,0
chr7 61968768 61969621 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 646 . 61968768 61969621 148,255,0
chr7 61968771 61969663 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 904 . 61968771 61969663 255,97,0
chr7 61968775 61969613 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 695 . 61968775 61969613 198,255,0
chr7 61968817 61969529 ID=SRX205093;Name=H3K9me1%20(@%20A549);Title=GSM1038462:%20H3K9me1-a549-3d-treated%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;treated%20twice%20with=10%20ng/mL%20TNF%20and%202%20ng/mL%20TGF%20for%2048hr%20each;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 751 . 61968817 61969529 255,253,0
chr7 61968916 61968988 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 243 . 61968916 61968988 0,247,255
chr7 61969232 61969291 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 256 . 61969232 61969291 0,255,248
chr7 61970211 61970576 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 939 . 61970211 61970576 255,62,0
chr7 61970216 61970559 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 860 . 61970216 61970559 255,142,0
chr7 61970221 61970564 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 856 . 61970221 61970564 255,146,0
chr7 61970225 61970570 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61970225 61970570 255,0,0
chr7 61970231 61970563 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61970231 61970563 255,0,0
chr7 61970232 61970555 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 747 . 61970232 61970555 251,255,0
chr7 61970247 61970530 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 619 . 61970247 61970530 121,255,0
chr7 61970259 61970542 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 862 . 61970259 61970542 255,140,0
chr7 61970260 61970484 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 538 . 61970260 61970484 38,255,0
chr7 61970263 61970482 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 520 . 61970263 61970482 20,255,0
chr7 61970265 61970480 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 555 . 61970265 61970480 56,255,0
chr7 61970271 61970476 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 543 . 61970271 61970476 43,255,0
chr7 61975579 61975997 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 308 . 61975579 61975997 0,255,195
chr7 61976214 61976335 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 646 . 61976214 61976335 148,255,0
chr7 61976248 61976313 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 363 . 61976248 61976313 0,255,139
chr7 61976250 61976307 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 300 . 61976250 61976307 0,255,204
chr7 61976252 61976301 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 264 . 61976252 61976301 0,255,240
chr7 61976252 61976309 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 239 . 61976252 61976309 0,243,255
chr7 61976254 61976310 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 251 . 61976254 61976310 0,255,253
chr7 61986220 61986254 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 419 . 61986220 61986254 0,255,82
chr7 100550766 100550883 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 794 . 100550766 100550883 255,210,0
chr7 107410649 107410697 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 458 . 107410649 107410697 0,255,42
chr7 107410650 107410696 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 425 . 107410650 107410696 0,255,76
chr7 107410650 107410696 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 404 . 107410650 107410696 0,255,97
chr7 145694445 145694509 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 806 . 145694445 145694509 255,197,0
chr7 145694448 145694508 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 798 . 145694448 145694508 255,206,0
chr7 157940304 157940407 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 277 . 157940304 157940407 0,255,227
chr8 45812 46085 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 382 . 45812 46085 0,255,120
chr8 2329300 2329401 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 321 . 2329300 2329401 0,255,182
chr8 43092780 43093192 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 794 . 43092780 43093192 255,210,0
chr8 43092843 43093177 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 694 . 43092843 43093177 197,255,0
chr8 43092853 43093178 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 605 . 43092853 43093178 107,255,0
chr8 43092854 43093156 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 473 . 43092854 43093156 0,255,27
chr8 43092860 43093164 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 521 . 43092860 43093164 21,255,0
chr8 43092862 43093277 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 693 . 43092862 43093277 196,255,0
chr8 43092874 43092987 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 697 . 43092874 43092987 200,255,0
chr8 43092876 43093006 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 995 . 43092876 43093006 255,5,0
chr8 43092881 43093001 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 837 . 43092881 43093001 255,166,0
chr8 43092882 43092996 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 739 . 43092882 43092996 243,255,0
chr8 43092884 43093006 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 922 . 43092884 43093006 255,79,0
chr8 43094756 43094933 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 43094756 43094933 255,0,0
chr8 43094767 43094900 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 43094767 43094900 255,0,0
chr8 43094768 43094896 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 43094768 43094896 255,0,0
chr8 43094769 43094897 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 43094769 43094897 255,0,0
chr8 43094770 43094898 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 43094770 43094898 255,0,0
chr8 43094772 43094881 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 663 . 43094772 43094881 166,255,0
chr8 43095173 43095230 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 363 . 43095173 43095230 0,255,139
chr8 43095902 43095962 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 351 . 43095902 43095962 0,255,151
chr8 43095902 43095968 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 425 . 43095902 43095968 0,255,76
chr8 43095903 43095969 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 395 . 43095903 43095969 0,255,107
chr8 43095904 43095966 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 359 . 43095904 43095966 0,255,143
chr8 43095915 43095970 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 451 . 43095915 43095970 0,255,49
chr8 43772273 43772317 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 629 . 43772273 43772317 131,255,0
chr8 43772275 43772315 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 680 . 43772275 43772315 183,255,0
chr8 43772276 43772316 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 582 . 43772276 43772316 83,255,0
chr8 43772277 43772312 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 604 . 43772277 43772312 106,255,0
chr8 43772277 43772314 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 534 . 43772277 43772314 34,255,0
chr8 43772277 43772317 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 644 . 43772277 43772317 146,255,0
chr8 43793695 43794136 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 514 . 43793695 43794136 14,255,0
chr8 43793703 43794207 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 711 . 43793703 43794207 215,255,0
chr8 43793766 43794137 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43793766 43794137 255,0,0
chr8 43793771 43794135 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43793771 43794135 255,0,0
chr8 43793788 43793953 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 632 . 43793788 43793953 134,255,0
chr8 43793792 43793906 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 595 . 43793792 43793906 96,255,0
chr8 43793797 43794158 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 477 . 43793797 43794158 0,255,23
chr8 43793800 43793905 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 395 . 43793800 43793905 0,255,107
chr8 43793801 43793904 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 403 . 43793801 43793904 0,255,98
chr8 43793803 43793915 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 337 . 43793803 43793915 0,255,166
chr8 43793810 43793923 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 335 . 43793810 43793923 0,255,168
chr8 43794045 43794205 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 627 . 43794045 43794205 129,255,0
chr8 43820982 43821236 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 953 . 43820982 43821236 255,47,0
chr8 43820996 43821229 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43820996 43821229 255,0,0
chr8 43824640 43824897 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 767 . 43824640 43824897 255,237,0
chr8 43826905 43827315 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 519 . 43826905 43827315 19,255,0
chr8 43826919 43827349 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 467 . 43826919 43827349 0,255,33
chr8 43827954 43828220 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 971 . 43827954 43828220 255,29,0
chr8 43827966 43828209 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43827966 43828209 255,0,0
chr8 43831030 43831311 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43831030 43831311 255,0,0
chr8 43831045 43831332 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43831045 43831332 255,0,0
chr8 43835370 43835561 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 290 . 43835370 43835561 0,255,214
chr8 43837148 43837639 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43837148 43837639 255,0,0
chr8 43837156 43837643 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43837156 43837643 255,0,0
chr8 43837201 43837340 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 346 . 43837201 43837340 0,255,157
chr8 43838462 43838722 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43838462 43838722 255,0,0
chr8 43838475 43838741 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 43838475 43838741 255,0,0
chr8 43838543 43838730 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 660 . 43838543 43838730 163,255,0
chr8 43838579 43838712 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 391 . 43838579 43838712 0,255,111
chr8 43838586 43838715 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 495 . 43838586 43838715 0,255,5
chr8 46841483 46841838 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46841483 46841838 255,0,0
chr8 46841551 46841836 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46841551 46841836 255,0,0
chr8 46841639 46841781 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 308 . 46841639 46841781 0,255,195
chr8 46842444 46842566 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 236 . 46842444 46842566 0,240,255
chr8 46844024 46844457 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46844024 46844457 255,0,0
chr8 46844109 46844441 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46844109 46844441 255,0,0
chr8 46844249 46844435 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 268 . 46844249 46844435 0,255,236
chr8 46848312 46848656 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 743 . 46848312 46848656 247,255,0
chr8 46848318 46848648 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 732 . 46848318 46848648 236,255,0
chr8 46849068 46849919 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46849068 46849919 255,0,0
chr8 46849073 46850396 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 46849073 46850396 255,0,0
chr8 46850110 46850405 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 864 . 46850110 46850405 255,138,0
chr8 46855299 46855519 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 888 . 46855299 46855519 255,114,0
chr8 68497702 68497737 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 563 . 68497702 68497737 64,255,0
chr8 70602346 70602513 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 70602346 70602513 255,0,0
chr8 82754681 82754790 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 530 . 82754681 82754790 30,255,0
chr8 100508108 100508152 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 834 . 100508108 100508152 255,169,0
chr8 100508109 100508163 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 855 . 100508109 100508163 255,147,0
chr9 42819058 42819204 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 42819058 42819204 255,0,0
chr9 42819067 42819202 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 42819067 42819202 255,0,0
chr9 42819069 42819186 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 917 . 42819069 42819186 255,84,0
chr9 42819071 42819185 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 864 . 42819071 42819185 255,138,0
chr9 42819073 42819185 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 823 . 42819073 42819185 255,180,0
chr9 42819073 42819189 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 892 . 42819073 42819189 255,110,0
chr9 42819105 42819150 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 567 . 42819105 42819150 68,255,0
chr9 42819113 42819153 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 514 . 42819113 42819153 14,255,0
chr9 42819115 42819150 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 386 . 42819115 42819150 0,255,116
chr9 42819115 42819150 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 445 . 42819115 42819150 0,255,56
chr9 42819116 42819156 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 448 . 42819116 42819156 0,255,53
chr9 42819118 42819153 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 424 . 42819118 42819153 0,255,77
chr9 66800761 66800875 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 643 . 66800761 66800875 145,255,0
chr9 66800776 66800855 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 388 . 66800776 66800855 0,255,114
chr9 66800778 66800860 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 339 . 66800778 66800860 0,255,164
chr9 66800780 66800853 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 320 . 66800780 66800853 0,255,183
chr9 66833151 66833195 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 526 . 66833151 66833195 26,255,0
chr9 66833153 66833199 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 525 . 66833153 66833199 25,255,0
chr9 66833155 66833191 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 436 . 66833155 66833191 0,255,65
chr9 66833155 66833196 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 441 . 66833155 66833196 0,255,60
chr9 66833155 66833202 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 470 . 66833155 66833202 0,255,30
chr9 66833652 66834073 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 501 . 66833652 66834073 1,255,0
chr9 66833659 66834065 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 598 . 66833659 66834065 99,255,0
chr9 66833661 66833954 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 539 . 66833661 66833954 39,255,0
chr9 66833665 66834043 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 603 . 66833665 66834043 105,255,0
chr9 66833791 66833941 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 66833791 66833941 255,0,0
chr9 66833793 66833923 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 66833793 66833923 255,0,0
chr9 66833796 66833915 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 914 . 66833796 66833915 255,87,0
chr9 66833797 66833924 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 875 . 66833797 66833924 255,127,0
chr9 66833801 66833919 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 906 . 66833801 66833919 255,95,0
chr9 66833801 66833921 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 876 . 66833801 66833921 255,126,0
chr9 66970971 66971398 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 499 . 66970971 66971398 0,255,1
chr9 66970977 66971515 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 66970977 66971515 255,0,0
chr9 66970986 66971511 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 66970986 66971511 255,0,0
chr9 66970995 66971462 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 66970995 66971462 255,0,0
chr9 66970995 66971480 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 66970995 66971480 255,0,0
chr9 66971006 66971432 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 66971006 66971432 255,0,0
chr9 66971013 66971413 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 66971013 66971413 255,0,0
chr9 66971014 66971499 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 66971014 66971499 255,0,0
chr9 66971016 66971415 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 547 . 66971016 66971415 47,255,0
chr9 66971016 66971501 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 66971016 66971501 255,0,0
chr9 66971018 66971402 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 66971018 66971402 255,0,0
chr9 66971030 66971402 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 66971030 66971402 255,0,0
chr9 66971030 66971412 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 899 . 66971030 66971412 255,103,0
chr9 66971033 66971392 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 66971033 66971392 255,0,0
chr9 66971108 66971170 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 609 . 66971108 66971170 111,255,0
chr9 66971109 66971249 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 541 . 66971109 66971249 41,255,0
chr9 66971110 66971165 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 640 . 66971110 66971165 142,255,0
chr9 66971110 66971167 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 565 . 66971110 66971167 66,255,0
chr9 66971112 66971172 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 519 . 66971112 66971172 19,255,0
chr9 66971119 66971173 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 423 . 66971119 66971173 0,255,78
chr9 66971212 66971249 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 340 . 66971212 66971249 0,255,163
chr9 66971213 66971267 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 396 . 66971213 66971267 0,255,106
chr9 66971217 66971254 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 409 . 66971217 66971254 0,255,92
chr9 66971218 66971253 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 306 . 66971218 66971253 0,255,197
chr9 67320390 67320937 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 67320390 67320937 255,0,0
chr9 67320402 67320933 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 67320402 67320933 255,0,0
chr9 67320420 67321041 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 838 . 67320420 67321041 255,165,0
chr9 67320434 67320953 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 67320434 67320953 255,0,0
chr9 67320438 67320945 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 67320438 67320945 255,0,0
chr9 67320441 67320906 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 591 . 67320441 67320906 92,255,0
chr9 67320445 67320927 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 817 . 67320445 67320927 255,186,0
chr9 67320504 67320932 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 67320504 67320932 255,0,0
chr9 67320505 67320924 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 67320505 67320924 255,0,0
chr9 67320505 67320925 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 67320505 67320925 255,0,0
chr9 67320506 67320926 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 67320506 67320926 255,0,0
chr9 67320509 67320924 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 67320509 67320924 255,0,0
chr9 67320514 67320924 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 67320514 67320924 255,0,0
chr9 67320545 67320967 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 563 . 67320545 67320967 64,255,0
chr9 67320546 67320601 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 355 . 67320546 67320601 0,255,147
chr9 67320555 67320591 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 367 . 67320555 67320591 0,255,135
chr9 67320776 67320823 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 516 . 67320776 67320823 16,255,0
chr9 67320780 67320822 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 561 . 67320780 67320822 62,255,0
chr9 67320781 67320824 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 491 . 67320781 67320824 0,255,9
chr9 67320782 67320819 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 432 . 67320782 67320819 0,255,69
chr9 67320782 67320903 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 535 . 67320782 67320903 35,255,0
chr9 67320785 67320822 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 506 . 67320785 67320822 6,255,0
chr9 67320859 67320896 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 432 . 67320859 67320896 0,255,69
chr9 69710793 69711331 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 69710793 69711331 255,0,0
chr9 69710793 69711339 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 69710793 69711339 255,0,0
chr9 69710796 69711342 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 69710796 69711342 255,0,0
chr9 69710801 69711326 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 1000 . 69710801 69711326 255,0,0
chr9 69710832 69711274 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 69710832 69711274 255,0,0
chr9 69710839 69711291 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 69710839 69711291 255,0,0
chr9 69710850 69711323 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 749 . 69710850 69711323 253,255,0
chr9 69710906 69711335 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 69710906 69711335 255,0,0
chr9 69710908 69711308 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 69710908 69711308 255,0,0
chr9 69710912 69711315 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 69710912 69711315 255,0,0
chr9 69710913 69711308 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 69710913 69711308 255,0,0
chr9 69710914 69711308 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 69710914 69711308 255,0,0
chr9 69710917 69711307 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 69710917 69711307 255,0,0
chr9 69710953 69711004 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 471 . 69710953 69711004 0,255,29
chr9 69710962 69711319 ID=SRX641966;Name=H3K9me1%20(@%20Unclassified);Title=GSM1422996:%20Pmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shGFP;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 344 . 69710962 69711319 0,255,159
chr9 69710965 69711002 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 376 . 69710965 69711002 0,255,126
chr9 69710967 69711006 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 360 . 69710967 69711006 0,255,142
chr9 69710968 69711011 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 319 . 69710968 69711011 0,255,184
chr9 69711086 69711136 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 352 . 69711086 69711136 0,255,150
chr9 69711087 69711149 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 397 . 69711087 69711149 0,255,105
chr9 69711100 69711135 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 356 . 69711100 69711135 0,255,146
chr9 70076673 70076819 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 70076673 70076819 255,0,0
chr9 70076678 70076807 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 938 . 70076678 70076807 255,63,0
chr9 70076693 70076806 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 869 . 70076693 70076806 255,133,0
chr9 70076695 70076810 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 857 . 70076695 70076810 255,145,0
chr9 70076696 70076808 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 850 . 70076696 70076808 255,153,0
chr9 70076698 70076805 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 740 . 70076698 70076805 244,255,0
chr9 70076726 70076774 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 498 . 70076726 70076774 0,255,2
chr9 70076729 70076776 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 479 . 70076729 70076776 0,255,21
chr9 70076730 70076765 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 353 . 70076730 70076765 0,255,149
chr9 70076731 70076764 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 361 . 70076731 70076764 0,255,141
chr9 70076731 70076778 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 534 . 70076731 70076778 34,255,0
chr9 70076732 70076767 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 388 . 70076732 70076767 0,255,114
chr9 70327419 70327563 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 70327419 70327563 255,0,0
chr9 70327421 70327546 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 905 . 70327421 70327546 255,96,0
chr9 70327434 70327553 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 940 . 70327434 70327553 255,61,0
chr9 70327436 70327548 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 873 . 70327436 70327548 255,129,0
chr9 70327436 70327553 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 899 . 70327436 70327553 255,103,0
chr9 70327437 70327547 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 739 . 70327437 70327547 243,255,0
chr9 70327465 70327510 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 479 . 70327465 70327510 0,255,21
chr9 70327468 70327504 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 377 . 70327468 70327504 0,255,125
chr9 70327470 70327516 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 593 . 70327470 70327516 94,255,0
chr9 70327471 70327520 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 508 . 70327471 70327520 8,255,0
chr9 70327473 70327508 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 381 . 70327473 70327508 0,255,121
chr9 70327473 70327511 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 437 . 70327473 70327511 0,255,64
chr9 72653085 72653378 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 72653085 72653378 255,0,0
chr9 72653085 72653386 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 72653085 72653386 255,0,0
chr9 72653106 72653361 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 919 . 72653106 72653361 255,82,0
chr9 72653112 72653361 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 72653112 72653361 255,0,0
chr9 72653115 72653349 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 649 . 72653115 72653349 151,255,0
chr9 72653117 72653152 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 476 . 72653117 72653152 0,255,24
chr9 72653117 72653355 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 694 . 72653117 72653355 197,255,0
chr9 72653120 72653157 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 507 . 72653120 72653157 7,255,0
chr9 72653120 72653163 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 496 . 72653120 72653163 0,255,4
chr9 72653278 72653330 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 278 . 72653278 72653330 0,255,226
chr9 72653507 72653544 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 586 . 72653507 72653544 87,255,0
chr9 72653510 72653544 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 474 . 72653510 72653544 0,255,26
chr9 78790138 78790177 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 563 . 78790138 78790177 64,255,0
chr9 78790138 78790182 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 430 . 78790138 78790182 0,255,71
chr9 78790139 78790181 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 411 . 78790139 78790181 0,255,90
chr9 78790140 78790177 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 320 . 78790140 78790177 0,255,183
chr9 78790140 78790184 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 334 . 78790140 78790184 0,255,169
chr9 78790140 78790189 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 412 . 78790140 78790189 0,255,89
chr9_gl000199_random 31569 31604 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 322 . 31569 31604 0,255,181
chr9_gl000199_random 34231 34650 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 829 . 34231 34650 255,174,0
chr9_gl000199_random 34231 34654 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 34231 34654 255,0,0
chr9_gl000199_random 34253 34675 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 919 . 34253 34675 255,82,0
chr9_gl000199_random 34278 34675 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 869 . 34278 34675 255,133,0
chr9_gl000199_random 34296 34669 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 34296 34669 255,0,0
chr9_gl000199_random 34304 34652 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 34304 34652 255,0,0
chr9_gl000199_random 34383 34529 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 991 . 34383 34529 255,9,0
chr9_gl000199_random 34387 34532 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 34387 34532 255,0,0
chr9_gl000199_random 34389 34529 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 34389 34529 255,0,0
chr9_gl000199_random 34392 34533 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 34392 34533 255,0,0
chr9_gl000199_random 34392 34533 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 34392 34533 255,0,0
chr9_gl000199_random 34394 34527 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 34394 34527 255,0,0
chr9_gl000199_random 34434 34485 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 661 . 34434 34485 164,255,0
chr9_gl000199_random 34440 34478 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 538 . 34440 34478 38,255,0
chr9_gl000199_random 34440 34480 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 553 . 34440 34480 54,255,0
chr9_gl000199_random 34441 34475 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 432 . 34441 34475 0,255,69
chr9_gl000199_random 34441 34477 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 485 . 34441 34477 0,255,15
chr9_gl000199_random 34442 34476 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 418 . 34442 34476 0,255,83
chr9_gl000199_random 40122 40489 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 675 . 40122 40489 178,255,0
chr9_gl000199_random 40127 40493 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 750 . 40127 40493 255,255,0
chr9_gl000199_random 44187 44456 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 705 . 44187 44456 209,255,0
chr9_gl000199_random 44196 44430 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 663 . 44196 44430 166,255,0
chr9_gl000199_random 44862 45120 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 790 . 44862 45120 255,214,0
chr9_gl000199_random 44870 45107 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 941 . 44870 45107 255,60,0
chr9_gl000199_random 46254 46475 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 884 . 46254 46475 255,118,0
chr9_gl000199_random 49731 49978 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 590 . 49731 49978 91,255,0
chr9_gl000199_random 49732 49866 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 442 . 49732 49866 0,255,59
chr9_gl000199_random 51142 51445 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 306 . 51142 51445 0,255,197
chr9_gl000199_random 57026 57378 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 57026 57378 255,0,0
chr9_gl000199_random 57036 57375 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 57036 57375 255,0,0
chr9_gl000199_random 60715 60826 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 429 . 60715 60826 0,255,72
chr9_gl000199_random 60738 60960 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 523 . 60738 60960 23,255,0
chr9_gl000199_random 66878 67293 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 676 . 66878 67293 179,255,0
chr9_gl000199_random 66937 67289 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 486 . 66937 67289 0,255,14
chr9_gl000199_random 72576 73139 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 72576 73139 255,0,0
chr9_gl000199_random 72640 73118 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 72640 73118 255,0,0
chr9_gl000199_random 72697 73034 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 524 . 72697 73034 24,255,0
chr9_gl000199_random 72705 73061 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 671 . 72705 73061 174,255,0
chr9_gl000199_random 72728 73051 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 484 . 72728 73051 0,255,16
chr9_gl000199_random 72838 72998 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 598 . 72838 72998 99,255,0
chr9_gl000199_random 72883 73005 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 513 . 72883 73005 13,255,0
chr9_gl000199_random 79112 79481 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 609 . 79112 79481 111,255,0
chr9_gl000199_random 79129 79465 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 486 . 79129 79465 0,255,14
chr9_gl000199_random 82888 83221 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 82888 83221 255,0,0
chr9_gl000199_random 82904 83190 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 831 . 82904 83190 255,172,0
chr9_gl000199_random 84237 84546 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 976 . 84237 84546 255,24,0
chr9_gl000199_random 84261 84503 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 912 . 84261 84503 255,89,0
chr9_gl000199_random 86305 86524 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 912 . 86305 86524 255,89,0
chr9_gl000199_random 91473 92076 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 516 . 91473 92076 16,255,0
chr9_gl000199_random 91473 92095 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 91473 92095 255,0,0
chr9_gl000199_random 91477 92101 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 91477 92101 255,0,0
chr9_gl000199_random 91496 91613 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 443 . 91496 91613 0,255,58
chr9_gl000199_random 91521 92049 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 476 . 91521 92049 0,255,24
chr9_gl000199_random 91636 92002 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 300 . 91636 92002 0,255,204
chr9_gl000199_random 91745 92036 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 312 . 91745 92036 0,255,191
chr9_gl000199_random 91875 92030 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 440 . 91875 92030 0,255,61
chr9_gl000199_random 92280 92812 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 975 . 92280 92812 255,25,0
chr9_gl000199_random 92296 92834 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 92296 92834 255,0,0
chr9_gl000199_random 98909 99034 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 98909 99034 255,0,0
chr9_gl000199_random 98914 99019 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 683 . 98914 99019 186,255,0
chr9_gl000199_random 107022 107447 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 107022 107447 255,0,0
chr9_gl000199_random 107042 107433 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 107042 107433 255,0,0
chr9_gl000199_random 108018 108322 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 647 . 108018 108322 149,255,0
chr9_gl000199_random 108029 108299 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 543 . 108029 108299 43,255,0
chr9_gl000199_random 108982 109199 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 651 . 108982 109199 154,255,0
chr9_gl000199_random 114460 114744 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 709 . 114460 114744 213,255,0
chr9_gl000199_random 114480 114753 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 678 . 114480 114753 181,255,0
chr9_gl000199_random 118577 118981 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 543 . 118577 118981 43,255,0
chr9_gl000199_random 118583 118962 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 564 . 118583 118962 65,255,0
chr9_gl000199_random 124301 124953 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 805 . 124301 124953 255,198,0
chr9_gl000199_random 124446 124956 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 853 . 124446 124956 255,149,0
chr9_gl000199_random 129653 129926 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 991 . 129653 129926 255,9,0
chr9_gl000199_random 129656 129901 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 928 . 129656 129901 255,73,0
chr9_gl000199_random 134240 134501 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 748 . 134240 134501 252,255,0
chr9_gl000199_random 134240 134533 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 890 . 134240 134533 255,112,0
chr9_gl000199_random 136852 137293 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 601 . 136852 137293 103,255,0
chr9_gl000199_random 136856 137315 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 652 . 136856 137315 155,255,0
chr9_gl000199_random 141335 141606 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 453 . 141335 141606 0,255,47
chr9_gl000199_random 154606 154820 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 869 . 154606 154820 255,133,0
chr9_gl000199_random 156294 156595 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 942 . 156294 156595 255,59,0
chr9_gl000199_random 156316 156601 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 156316 156601 255,0,0
chr9_gl000199_random 165601 165837 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 970 . 165601 165837 255,30,0
chr9_gl000199_random 165601 165846 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 650 . 165601 165846 153,255,0
chr9_gl000199_random 168096 168676 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 168096 168676 255,0,0
chr9_gl000199_random 168104 168515 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 550 . 168104 168515 51,255,0
chr9_gl000199_random 168109 168510 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 655 . 168109 168510 158,255,0
chr9_gl000199_random 168114 168604 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 168114 168604 255,0,0
chr9_gl000199_random 168199 168504 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 473 . 168199 168504 0,255,27
chr9_gl000199_random 168225 168370 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 870 . 168225 168370 255,132,0
chr9_gl000199_random 168255 168387 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 968 . 168255 168387 255,32,0
chr9_gl000199_random 168260 168371 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 698 . 168260 168371 201,255,0
chr9_gl000199_random 168261 168369 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 696 . 168261 168369 199,255,0
chr9_gl000199_random 168261 168370 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 633 . 168261 168370 135,255,0
chr9_gl000199_random 168263 168373 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 725 . 168263 168373 229,255,0
chr9_gl000199_random 168287 168322 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 339 . 168287 168322 0,255,164
chr9_gl000199_random 168288 168322 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 362 . 168288 168322 0,255,140
chr9_gl000199_random 168288 168322 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 308 . 168288 168322 0,255,195
chrM 16368 16494 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 406 . 16368 16494 0,255,95
chrUn_gl000212 40497 41240 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 40497 41240 255,0,0
chrUn_gl000212 40545 41140 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 945 . 40545 41140 255,56,0
chrUn_gl000212 40552 40685 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 675 . 40552 40685 178,255,0
chrUn_gl000212 40552 40697 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 864 . 40552 40697 255,138,0
chrUn_gl000212 40556 40680 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 595 . 40556 40680 96,255,0
chrUn_gl000212 40563 40676 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 576 . 40563 40676 77,255,0
chrUn_gl000212 40569 40676 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 597 . 40569 40676 98,255,0
chrUn_gl000212 40576 40694 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 662 . 40576 40694 165,255,0
chrUn_gl000212 40592 41135 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 40592 41135 255,0,0
chrUn_gl000212 40607 41087 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 950 . 40607 41087 255,51,0
chrUn_gl000212 40625 41117 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 593 . 40625 41117 94,255,0
chrUn_gl000212 40783 40948 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 40783 40948 255,0,0
chrUn_gl000212 40787 40929 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 40787 40929 255,0,0
chrUn_gl000212 40791 40932 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 40791 40932 255,0,0
chrUn_gl000212 40811 40923 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 756 . 40811 40923 255,248,0
chrUn_gl000212 40812 40925 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 733 . 40812 40925 237,255,0
chrUn_gl000212 40846 40912 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 472 . 40846 40912 0,255,28
chrUn_gl000212 40847 40910 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 451 . 40847 40910 0,255,49
chrUn_gl000212 40849 40908 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 378 . 40849 40908 0,255,124
chrUn_gl000214 64327 64556 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 739 . 64327 64556 243,255,0
chrUn_gl000214 64332 64736 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 675 . 64332 64736 178,255,0
chrUn_gl000214 64357 64924 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 447 . 64357 64924 0,255,54
chrUn_gl000214 64362 65259 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 64362 65259 255,0,0
chrUn_gl000214 64366 64918 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 435 . 64366 64918 0,255,66
chrUn_gl000214 64367 64912 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 457 . 64367 64912 0,255,43
chrUn_gl000214 64371 64919 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 393 . 64371 64919 0,255,109
chrUn_gl000214 64381 64678 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 310 . 64381 64678 0,255,193
chrUn_gl000214 64405 65224 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 712 . 64405 65224 216,255,0
chrUn_gl000214 64809 65136 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 485 . 64809 65136 0,255,15
chrUn_gl000214 64830 65313 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 640 . 64830 65313 142,255,0
chrUn_gl000214 64837 65174 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 373 . 64837 65174 0,255,129
chrUn_gl000214 64848 65166 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 393 . 64848 65166 0,255,109
chrUn_gl000214 65019 65302 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 555 . 65019 65302 56,255,0
chrUn_gl000214 65025 65300 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 780 . 65025 65300 255,224,0
chrUn_gl000214 65039 65276 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 405 . 65039 65276 0,255,96
chrUn_gl000214 65039 65300 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 540 . 65039 65300 40,255,0
chrUn_gl000214 65047 65274 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 385 . 65047 65274 0,255,117
chrUn_gl000214 65566 65666 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 547 . 65566 65666 47,255,0
chrUn_gl000214 65569 65680 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 452 . 65569 65680 0,255,48
chrUn_gl000214 65572 65673 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 534 . 65572 65673 34,255,0
chrUn_gl000214 134358 134771 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 305 . 134358 134771 0,255,198
chrUn_gl000216 1501 1846 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 432 . 1501 1846 0,255,69
chrUn_gl000216 1504 1636 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 572 . 1504 1636 73,255,0
chrUn_gl000216 1507 1627 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 568 . 1507 1627 69,255,0
chrUn_gl000216 15078 15227 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 670 . 15078 15227 173,255,0
chrUn_gl000216 15080 15204 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 496 . 15080 15204 0,255,4
chrUn_gl000216 15099 15222 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 514 . 15099 15222 14,255,0
chrUn_gl000216 15101 15227 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 508 . 15101 15227 8,255,0
chrUn_gl000216 75649 76120 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 75649 76120 255,0,0
chrUn_gl000216 75651 76112 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 75651 76112 255,0,0
chrUn_gl000216 75677 76068 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 648 . 75677 76068 150,255,0
chrUn_gl000216 75678 76062 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 556 . 75678 76062 57,255,0
chrUn_gl000216 75728 76017 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 447 . 75728 76017 0,255,54
chrUn_gl000216 75744 76028 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 482 . 75744 76028 0,255,18
chrUn_gl000216 75793 75957 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 499 . 75793 75957 0,255,1
chrUn_gl000216 138022 138307 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 138022 138307 255,0,0
chrUn_gl000216 138030 138285 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 757 . 138030 138285 255,247,0
chrUn_gl000216 145074 145498 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 145074 145498 255,0,0
chrUn_gl000216 145081 145496 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 145081 145496 255,0,0
chrUn_gl000216 145100 145442 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 529 . 145100 145442 29,255,0
chrUn_gl000216 145172 145502 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 145172 145502 255,0,0
chrUn_gl000216 145177 145370 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 809 . 145177 145370 255,194,0
chrUn_gl000216 145187 145347 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 601 . 145187 145347 103,255,0
chrUn_gl000216 145188 145322 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 609 . 145188 145322 111,255,0
chrUn_gl000216 145192 145352 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 518 . 145192 145352 18,255,0
chrUn_gl000216 145196 145345 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 573 . 145196 145345 74,255,0
chrUn_gl000216 160143 160194 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 305 . 160143 160194 0,255,198
chrUn_gl000216 162332 162598 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 703 . 162332 162598 207,255,0
chrUn_gl000216 162344 162611 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 998 . 162344 162611 255,2,0
chrUn_gl000216 162450 162564 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 370 . 162450 162564 0,255,132
chrUn_gl000216 163514 163629 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 717 . 163514 163629 221,255,0
chrUn_gl000216 163540 163589 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 344 . 163540 163589 0,255,159
chrUn_gl000216 163544 163578 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 364 . 163544 163578 0,255,138
chrUn_gl000216 163545 163584 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 349 . 163545 163584 0,255,154
chrUn_gl000216 163547 163587 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 316 . 163547 163587 0,255,187
chrUn_gl000216 164261 164553 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 164261 164553 255,0,0
chrUn_gl000216 164295 164557 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 164295 164557 255,0,0
chrUn_gl000216 169404 169786 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 600 . 169404 169786 102,255,0
chrUn_gl000216 169406 169698 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 421 . 169406 169698 0,255,80
chrUn_gl000216 169440 169726 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 169440 169726 255,0,0
chrUn_gl000216 169450 169731 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 169450 169731 255,0,0
chrUn_gl000216 169496 169683 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 642 . 169496 169683 144,255,0
chrUn_gl000216 169496 169687 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 767 . 169496 169687 255,237,0
chrUn_gl000216 169519 169626 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 339 . 169519 169626 0,255,164
chrUn_gl000220 101682 101991 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 495 . 101682 101991 0,255,5
chrUn_gl000220 101688 102077 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 847 . 101688 102077 255,156,0
chrUn_gl000220 101707 102557 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 730 . 101707 102557 234,255,0
chrUn_gl000220 102182 102437 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 386 . 102182 102437 0,255,116
chrUn_gl000220 102350 102902 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 308 . 102350 102902 0,255,195
chrUn_gl000220 102778 103048 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 275 . 102778 103048 0,255,229
chrUn_gl000220 103155 103815 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 873 . 103155 103815 255,129,0
chrUn_gl000220 103181 103444 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 400 . 103181 103444 0,255,102
chrUn_gl000220 103222 103778 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 353 . 103222 103778 0,255,149
chrUn_gl000220 103540 103993 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 350 . 103540 103993 0,255,153
chrUn_gl000220 103690 103996 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 421 . 103690 103996 0,255,80
chrUn_gl000220 104384 104667 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 327 . 104384 104667 0,255,176
chrUn_gl000220 110165 110361 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 224 . 110165 110361 0,228,255
chrUn_gl000220 110314 110790 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 469 . 110314 110790 0,255,31
chrUn_gl000220 110514 110679 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 264 . 110514 110679 0,255,240
chrUn_gl000220 153911 154055 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 291 . 153911 154055 0,255,213
chrUn_gl000220 154271 154675 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 360 . 154271 154675 0,255,142
chrUn_gl000220 158775 159291 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 342 . 158775 159291 0,255,161
chrUn_gl000220 159005 159291 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 322 . 159005 159291 0,255,181
chrUn_gl000220 159705 160117 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 422 . 159705 160117 0,255,79
chrUn_gl000220 159710 160164 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 334 . 159710 160164 0,255,169
chrUn_gl000220 159816 160066 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 281 . 159816 160066 0,255,223
chrUn_gl000220 160975 161237 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 415 . 160975 161237 0,255,86
chrUn_gl000220 161081 161404 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 304 . 161081 161404 0,255,199
chrUn_gl000220 161540 161740 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 466 . 161540 161740 0,255,34
chrUn_gl000222 84152 84618 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 84152 84618 255,0,0
chrUn_gl000222 84184 84615 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 84184 84615 255,0,0
chrUn_gl000222 84254 84584 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 84254 84584 255,0,0
chrUn_gl000222 84259 84556 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 769 . 84259 84556 255,235,0
chrUn_gl000222 84259 84558 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 703 . 84259 84558 207,255,0
chrUn_gl000222 84267 84501 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 621 . 84267 84501 123,255,0
chrUn_gl000222 84279 84533 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 596 . 84279 84533 97,255,0
chrUn_gl000224 4024 4590 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 426 . 4024 4590 0,255,75
chrUn_gl000224 17970 18098 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 339 . 17970 18098 0,255,164
chrUn_gl000224 17982 19066 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 646 . 17982 19066 148,255,0
chrUn_gl000224 18632 19049 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 470 . 18632 19049 0,255,30
chrUn_gl000225 6706 7002 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 6706 7002 255,0,0
chrUn_gl000225 6719 6993 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 6719 6993 255,0,0
chrUn_gl000225 6786 6951 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 982 . 6786 6951 255,18,0
chrUn_gl000225 6805 6934 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 571 . 6805 6934 72,255,0
chrUn_gl000225 6827 6932 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 398 . 6827 6932 0,255,104
chrUn_gl000225 6832 6940 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 508 . 6832 6940 8,255,0
chrUn_gl000225 17068 17300 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 667 . 17068 17300 170,255,0
chrUn_gl000225 25506 25807 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 25506 25807 255,0,0
chrUn_gl000225 25507 25795 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 25507 25795 255,0,0
chrUn_gl000225 25579 25717 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 740 . 25579 25717 244,255,0
chrUn_gl000225 25582 25729 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 871 . 25582 25729 255,131,0
chrUn_gl000225 25592 25701 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 564 . 25592 25701 65,255,0
chrUn_gl000225 25592 25701 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 580 . 25592 25701 81,255,0
chrUn_gl000225 25593 25701 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 582 . 25593 25701 83,255,0
chrUn_gl000225 33641 33766 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 637 . 33641 33766 139,255,0
chrUn_gl000225 33648 33767 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 644 . 33648 33767 146,255,0
chrUn_gl000225 50785 51027 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 50785 51027 255,0,0
chrUn_gl000225 50829 50972 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 952 . 50829 50972 255,48,0
chrUn_gl000225 50830 50965 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 758 . 50830 50965 255,246,0
chrUn_gl000225 50876 50911 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 394 . 50876 50911 0,255,108
chrUn_gl000225 56076 56310 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 56076 56310 255,0,0
chrUn_gl000225 56152 56263 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 525 . 56152 56263 25,255,0
chrUn_gl000225 67293 67582 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 511 . 67293 67582 11,255,0
chrUn_gl000225 67338 67614 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 67338 67614 255,0,0
chrUn_gl000225 67355 67620 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 67355 67620 255,0,0
chrUn_gl000225 67527 67563 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 485 . 67527 67563 0,255,15
chrUn_gl000225 70605 71232 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 933 . 70605 71232 255,68,0
chrUn_gl000225 70763 71256 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 655 . 70763 71256 158,255,0
chrUn_gl000225 85553 85766 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 747 . 85553 85766 251,255,0
chrUn_gl000225 85610 85739 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 967 . 85610 85739 255,33,0
chrUn_gl000225 85610 85743 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 85610 85743 255,0,0
chrUn_gl000225 85618 85721 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 620 . 85618 85721 122,255,0
chrUn_gl000225 85665 85701 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 428 . 85665 85701 0,255,73
chrUn_gl000225 85666 85701 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 439 . 85666 85701 0,255,62
chrUn_gl000225 85666 85703 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 435 . 85666 85703 0,255,66
chrUn_gl000225 85667 85701 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 404 . 85667 85701 0,255,97
chrUn_gl000225 92605 92853 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 724 . 92605 92853 228,255,0
chrUn_gl000225 99177 99526 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 99177 99526 255,0,0
chrUn_gl000225 99193 99520 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 99193 99520 255,0,0
chrUn_gl000225 99262 99436 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 419 . 99262 99436 0,255,82
chrUn_gl000225 99299 99406 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 335 . 99299 99406 0,255,168
chrUn_gl000225 99299 99422 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 347 . 99299 99422 0,255,156
chrUn_gl000225 99307 99414 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 354 . 99307 99414 0,255,148
chrUn_gl000225 101622 101747 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 512 . 101622 101747 12,255,0
chrUn_gl000225 102415 102527 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 533 . 102415 102527 33,255,0
chrUn_gl000225 111462 111708 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 944 . 111462 111708 255,57,0
chrUn_gl000225 111480 111613 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 710 . 111480 111613 214,255,0
chrUn_gl000225 111482 111726 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 602 . 111482 111726 104,255,0
chrUn_gl000225 112345 112925 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 997 . 112345 112925 255,3,0
chrUn_gl000225 120602 120733 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 626 . 120602 120733 128,255,0
chrUn_gl000225 125776 126028 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 599 . 125776 126028 100,255,0
chrUn_gl000225 130397 130645 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 546 . 130397 130645 46,255,0
chrUn_gl000225 130410 130631 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 668 . 130410 130631 171,255,0
chrUn_gl000225 130444 130590 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 371 . 130444 130590 0,255,131
chrUn_gl000225 133612 133912 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 790 . 133612 133912 255,214,0
chrUn_gl000225 133661 133910 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 133661 133910 255,0,0
chrUn_gl000225 133702 133852 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 814 . 133702 133852 255,189,0
chrUn_gl000225 133703 133845 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 916 . 133703 133845 255,85,0
chrUn_gl000225 133719 133833 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 481 . 133719 133833 0,255,19
chrUn_gl000225 133725 133829 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 415 . 133725 133829 0,255,86
chrUn_gl000225 133729 133834 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 463 . 133729 133834 0,255,37
chrUn_gl000225 133730 133837 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 483 . 133730 133837 0,255,17
chrUn_gl000225 196959 197076 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 728 . 196959 197076 232,255,0
chrUn_gl000225 196980 197035 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 808 . 196980 197035 255,195,0
chrUn_gl000225 196982 197032 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 614 . 196982 197032 116,255,0
chrUn_gl000225 196982 197034 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 653 . 196982 197034 156,255,0
chrUn_gl000225 196982 197035 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 556 . 196982 197035 57,255,0
chrUn_gl000225 196983 197032 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 630 . 196983 197032 132,255,0
chrUn_gl000225 196983 197033 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 647 . 196983 197033 149,255,0
chrUn_gl000226 1548 2014 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 575 . 1548 2014 76,255,0
chrUn_gl000226 1560 2053 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 451 . 1560 2053 0,255,49
chrUn_gl000226 3184 3430 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 369 . 3184 3430 0,255,133
chrUn_gl000226 3186 3474 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 405 . 3186 3474 0,255,96
chrUn_gl000226 5068 5450 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 290 . 5068 5450 0,255,214
chrUn_gl000226 5076 5399 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 253 . 5076 5399 0,255,251
chrUn_gl000226 6675 6956 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 213 . 6675 6956 0,217,255
chrUn_gl000226 6680 6978 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 291 . 6680 6978 0,255,213
chrUn_gl000226 12465 12689 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 508 . 12465 12689 8,255,0
chrUn_gl000226 13804 14044 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 705 . 13804 14044 209,255,0
chrUn_gl000226 14259 14879 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 14259 14879 255,0,0
chrUn_gl000226 14273 14891 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 960 . 14273 14891 255,40,0
chrUn_gl000226 14327 14830 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 454 . 14327 14830 0,255,46
chrUn_gl000226 14475 14829 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 351 . 14475 14829 0,255,151
chrUn_gl000226 14482 14827 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 363 . 14482 14827 0,255,139
chrUn_gl000226 14498 14827 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 384 . 14498 14827 0,255,118
chrUn_gl000226 14525 14904 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 310 . 14525 14904 0,255,193
chrUn_gl000228 27379 27709 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 27379 27709 255,0,0
chrUn_gl000228 27400 27707 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 843 . 27400 27707 255,160,0
chrUn_gl000228 27409 27685 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 708 . 27409 27685 212,255,0
chrUn_gl000228 27430 27597 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 498 . 27430 27597 0,255,2
chrUn_gl000228 27445 27573 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 454 . 27445 27573 0,255,46
chrUn_gl000228 27450 27556 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 389 . 27450 27556 0,255,113
chrUn_gl000228 117056 117783 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 117056 117783 255,0,0
chrUn_gl000228 117097 117792 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 117097 117792 255,0,0
chrUn_gl000228 117172 117305 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 762 . 117172 117305 255,242,0
chrUn_gl000228 117174 117300 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 786 . 117174 117300 255,218,0
chrUn_gl000228 118047 118869 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 118047 118869 255,0,0
chrUn_gl000228 118093 118883 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 118093 118883 255,0,0
chrUn_gl000228 118117 118795 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 889 . 118117 118795 255,113,0
chrUn_gl000228 118122 118592 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 118122 118592 255,0,0
chrUn_gl000228 118122 118779 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 712 . 118122 118779 216,255,0
chrUn_gl000228 118182 118809 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 558 . 118182 118809 59,255,0
chrUn_gl000228 118187 118775 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 749 . 118187 118775 253,255,0
chrUn_gl000228 118299 118599 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 118299 118599 255,0,0
chrUn_gl000228 118305 118604 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 344 . 118305 118604 0,255,159
chrUn_gl000228 118354 118572 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 480 . 118354 118572 0,255,20
chrUn_gl000228 118384 118567 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 457 . 118384 118567 0,255,43
chrUn_gl000228 118470 118570 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 557 . 118470 118570 58,255,0
chrUn_gl000228 118502 118540 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 239 . 118502 118540 0,243,255
chrUn_gl000228 118674 118819 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 683 . 118674 118819 186,255,0
chrUn_gl000228 118681 118800 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 461 . 118681 118800 0,255,39
chrUn_gl000235 270 519 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 971 . 270 519 255,29,0
chrUn_gl000235 278 553 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 641 . 278 553 143,255,0
chrUn_gl000235 353 486 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 814 . 353 486 255,189,0
chrUn_gl000243 20965 21094 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 617 . 20965 21094 119,255,0
chrUn_gl000243 21250 21381 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 248 . 21250 21381 0,252,255
chrX 55208091 55208126 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 574 . 55208091 55208126 75,255,0
chrX 58568374 58569126 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 653 . 58568374 58569126 156,255,0
chrX 58568797 58569134 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 605 . 58568797 58569134 107,255,0
chrX 58569364 58569882 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 421 . 58569364 58569882 0,255,80
chrX 58572890 58573214 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 433 . 58572890 58573214 0,255,68
chrX 58572966 58573244 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 502 . 58572966 58573244 2,255,0
chrX 58578667 58580245 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 904 . 58578667 58580245 255,97,0
chrX 58578763 58579454 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 812 . 58578763 58579454 255,191,0
chrX 58579612 58580238 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 758 . 58579612 58580238 255,246,0
chrX 61686573 61686822 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61686573 61686822 255,0,0
chrX 61686591 61686824 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61686591 61686824 255,0,0
chrX 61687257 61687575 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61687257 61687575 255,0,0
chrX 61687265 61687572 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61687265 61687572 255,0,0
chrX 61691453 61692139 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61691453 61692139 255,0,0
chrX 61691502 61692135 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61691502 61692135 255,0,0
chrX 61691626 61691998 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 402 . 61691626 61691998 0,255,99
chrX 61699223 61699465 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 552 . 61699223 61699465 53,255,0
chrX 61700517 61700790 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61700517 61700790 255,0,0
chrX 61700528 61700791 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61700528 61700791 255,0,0
chrX 61710578 61710845 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 951 . 61710578 61710845 255,49,0
chrX 61710586 61710813 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61710586 61710813 255,0,0
chrX 61711023 61711429 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61711023 61711429 255,0,0
chrX 61711172 61711431 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61711172 61711431 255,0,0
chrX 61712448 61712722 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 944 . 61712448 61712722 255,57,0
chrX 61712490 61712737 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61712490 61712737 255,0,0
chrX 61718601 61719093 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 937 . 61718601 61719093 255,64,0
chrX 61718602 61719102 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 61718602 61719102 255,0,0
chrX 61719392 61719887 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 924 . 61719392 61719887 255,77,0
chrX 61719418 61719890 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 835 . 61719418 61719890 255,168,0
chrX 61719739 61719848 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 707 . 61719739 61719848 211,255,0
chrX 61823486 61823594 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 661 . 61823486 61823594 164,255,0
chrX 61870817 61870930 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 617 . 61870817 61870930 119,255,0
chrX 61870834 61870884 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 566 . 61870834 61870884 67,255,0
chrX 61870835 61870883 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 575 . 61870835 61870883 76,255,0
chrX 61870836 61870887 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 619 . 61870836 61870887 121,255,0
chrX 61870840 61870881 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 529 . 61870840 61870881 29,255,0
chrX 61870841 61870879 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 481 . 61870841 61870879 0,255,19
chrX 61870848 61870884 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 414 . 61870848 61870884 0,255,87
chrX 155260066 155260357 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 974 . 155260066 155260357 255,26,0
chrX 155260071 155260256 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 534 . 155260071 155260256 34,255,0
chrX 155260084 155260341 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 580 . 155260084 155260341 81,255,0
chrX 155260100 155260263 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 337 . 155260100 155260263 0,255,166
chrX 155260291 155260347 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 238 . 155260291 155260347 0,242,255
chrY 4212836 4212881 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 822 . 4212836 4212881 255,181,0
chrY 8979516 8979560 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 865 . 8979516 8979560 255,137,0
chrY 13141008 13141193 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 864 . 13141008 13141193 255,138,0
chrY 13141009 13141205 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 899 . 13141009 13141205 255,103,0
chrY 13141022 13141156 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 738 . 13141022 13141156 242,255,0
chrY 13141029 13141150 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 474 . 13141029 13141150 0,255,26
chrY 13141030 13141155 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 517 . 13141030 13141155 17,255,0
chrY 13141031 13141169 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 625 . 13141031 13141169 127,255,0
chrY 13453316 13453465 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 371 . 13453316 13453465 0,255,131
chrY 13453340 13453446 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 291 . 13453340 13453446 0,255,213
chrY 13458417 13458458 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 314 . 13458417 13458458 0,255,189
chrY 13458428 13458465 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 319 . 13458428 13458465 0,255,184
chrY 13460925 13461299 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 13460925 13461299 255,0,0
chrY 13460950 13461288 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 13460950 13461288 255,0,0
chrY 13460971 13461103 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 834 . 13460971 13461103 255,169,0
chrY 13466314 13466529 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 576 . 13466314 13466529 77,255,0
chrY 13467850 13468282 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 447 . 13467850 13468282 0,255,54
chrY 13467850 13468311 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 591 . 13467850 13468311 92,255,0
chrY 13467941 13468287 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 418 . 13467941 13468287 0,255,83
chrY 13467950 13468285 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 359 . 13467950 13468285 0,255,143
chrY 13468009 13468401 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 13468009 13468401 255,0,0
chrY 13468079 13468403 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 13468079 13468403 255,0,0
chrY 13468183 13468311 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 679 . 13468183 13468311 182,255,0
chrY 13474284 13474708 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 13474284 13474708 255,0,0
chrY 13474291 13474683 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 13474291 13474683 255,0,0
chrY 13474420 13474534 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 484 . 13474420 13474534 0,255,16
chrY 13480193 13480471 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 816 . 13480193 13480471 255,187,0
chrY 13480224 13480453 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 662 . 13480224 13480453 165,255,0
chrY 13483295 13483410 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 770 . 13483295 13483410 255,234,0
chrY 13485504 13485751 ID=SRX6818878;Name=H3K9me1%20(@%20NB-4);Title=GSM4066997:%20shNC%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 665 . 13485504 13485751 168,255,0
chrY 13485513 13485823 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 521 . 13485513 13485823 21,255,0
chrY 13485514 13485758 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 1000 . 13485514 13485758 255,0,0
chrY 13485551 13485715 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 619 . 13485551 13485715 121,255,0
chrY 13485568 13485694 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 401 . 13485568 13485694 0,255,100
chrY 13680960 13680994 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 536 . 13680960 13680994 36,255,0
chrY 13694961 13695105 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 524 . 13694961 13695105 24,255,0
chrY 13704324 13704361 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 484 . 13704324 13704361 0,255,16
chrY 13704327 13704363 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 489 . 13704327 13704363 0,255,11
chrY 13801046 13801196 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 13801046 13801196 255,0,0
chrY 13801059 13801193 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 13801059 13801193 255,0,0
chrY 13808671 13808787 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 835 . 13808671 13808787 255,168,0
chrY 13808673 13808787 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 808 . 13808673 13808787 255,195,0
chrY 13811058 13811258 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 13811058 13811258 255,0,0
chrY 13811060 13811252 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 13811060 13811252 255,0,0
chrY 13811081 13811226 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 753 . 13811081 13811226 255,251,0
chrY 13811083 13811227 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 719 . 13811083 13811227 223,255,0
chrY 13811086 13811200 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 416 . 13811086 13811200 0,255,85
chrY 13811100 13811205 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 547 . 13811100 13811205 47,255,0
chrY 13833271 13833372 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 553 . 13833271 13833372 54,255,0
chrY 13833273 13833395 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 916 . 13833273 13833395 255,85,0
chrY 13833280 13833402 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 846 . 13833280 13833402 255,157,0
chrY 13838416 13838544 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 13838416 13838544 255,0,0
chrY 13838423 13838538 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 804 . 13838423 13838538 255,199,0
chrY 13842501 13842944 ID=SRX3832996;Name=H3K9me1%20(@%20Liver);Title=GSM3061123:%20HCC3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=674T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 1000 . 13842501 13842944 255,0,0
chrY 13842515 13842948 ID=SRX3832994;Name=H3K9me1%20(@%20Liver);Title=GSM3061121:%20HCC1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=HCC%20liver;sample%20id=661T;tissue=liver;disease%20state=HCC;chip%20antibody=ab8896,%20abcam; 868 . 13842515 13842948 255,134,0
chrY 13842526 13842946 ID=SRX3832995;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061122:%20Cirr3%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=674N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 773 . 13842526 13842946 255,231,0
chrY 13842531 13842933 ID=SRX3832993;Name=H3K9me1%20(@%20Liver%20Cirrhosis);Title=GSM3061120:%20Cirr1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=cirrhotic%20liver;sample%20id=661N;tissue=liver;disease%20state=cirrhosis;chip%20antibody=ab8896,%20abcam; 710 . 13842531 13842933 214,255,0
chrY 13842623 13842837 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 13842623 13842837 255,0,0
chrY 13842623 13842841 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 13842623 13842841 255,0,0
chrY 13842628 13842831 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 13842628 13842831 255,0,0
chrY 13842633 13842830 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 13842633 13842830 255,0,0
chrY 13842634 13842834 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 13842634 13842834 255,0,0
chrY 13842637 13842826 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 1000 . 13842637 13842826 255,0,0
chrY 13842643 13842946 ID=SRX3832992;Name=H3K9me1%20(@%20Liver);Title=GSM3061119:%20NL1%20h3k4me1%20h3k4me1%20chipseq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Liver;
source_name=normal%20liver;sample%20id=756;tissue=liver;disease%20state=normal;chip%20antibody=ab8896,%20abcam; 610 . 13842643 13842946 112,255,0
chrY 13842671 13842801 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 754 . 13842671 13842801 255,250,0
chrY 13842690 13842736 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 490 . 13842690 13842736 0,255,10
chrY 13842694 13842735 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 458 . 13842694 13842735 0,255,42
chrY 13842695 13842737 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 523 . 13842695 13842737 23,255,0
chrY 13842698 13842735 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 453 . 13842698 13842735 0,255,47
chrY 13842699 13842735 ID=SRX067454;Name=H3K9me1%20(@%20HUVEC);Title=GSM733703:%20Bernstein%20HUVEC%20H3K9me1;Cell%20group=Cardiovascular;
source_name=HUVEC;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=umbilical%20vein%20endothelial%20cells;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000060;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 441 . 13842699 13842735 0,255,60
chrY 13843925 13844083 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 13843925 13844083 255,0,0
chrY 13843929 13844080 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 13843929 13844080 255,0,0
chrY 13843947 13844066 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 680 . 13843947 13844066 183,255,0
chrY 13851964 13852103 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 13851964 13852103 255,0,0
chrY 13851966 13852102 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 1000 . 13851966 13852102 255,0,0
chrY 13851968 13852089 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 931 . 13851968 13852089 255,70,0
chrY 13851979 13852087 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 665 . 13851979 13852087 168,255,0
chrY 13859880 13860038 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 806 . 13859880 13860038 255,197,0
chrY 13859893 13860001 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 412 . 13859893 13860001 0,255,89
chrY 13868354 13868473 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 843 . 13868354 13868473 255,160,0
chrY 13868360 13868463 ID=SRX6964223;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113895:%200hrA%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 633 . 13868360 13868463 135,255,0
chrY 13868361 13868464 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 645 . 13868361 13868464 147,255,0
chrY 13868362 13868477 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 597 . 13868362 13868477 98,255,0
chrY 13868364 13868464 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 543 . 13868364 13868464 43,255,0
chrY 13868381 13868437 ID=SRX205092;Name=H3K9me1%20(@%20A549);Title=GSM1038461:%20H3K9me1-a549-3d-control%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Lung;
source_name=a549%203D%20culture;cell%20line=A549;chip%20antibody=H3K9me1;chip%20antibody%20vendor=Active%20Motif; 811 . 13868381 13868437 255,192,0
chrY 13868385 13868429 ID=SRX641894;Name=H3K9me1%20(@%20Melanocytes);Title=GSM1422924:%20Hmel-shGFP-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Epidermis;
source_name=Hmel-shGFP;partially%20transformed%20melanocytic%20line=HMEL;clone%20subtype=Hmel-shGFP;cell%20phentype=non-tumorigenic%20variant;chip%20antibody=H3K9ME1; 531 . 13868385 13868429 31,255,0
chrY 13868387 13868425 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 525 . 13868387 13868425 25,255,0
chrY 13868387 13868429 ID=SRX642002;Name=H3K9me1%20(@%20Unclassified);Title=GSM1423032:%20Pmel-shPTEN-H3K9ME1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=NA;
source_name=Pmel-shPTEN;partially%20transformed%20melanocytic%20line=PMEL;clone%20subtype=Pmel-shPTEN;cell%20phentype=tumorigenic%20variant;chip%20antibody=H3K9ME1; 544 . 13868387 13868429 44,255,0
chrY 28784365 28784479 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 660 . 28784365 28784479 163,255,0
chrY 28784365 28784481 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 598 . 28784365 28784481 99,255,0
chrY 58819700 58819743 ID=SRX067406;Name=H3K9me1%20(@%20NHEK);Title=GSM733655:%20Bernstein%20NHEK%20H3K9me1;Cell%20group=Epidermis;
source_name=NHEK;biomaterial_provider=Lonza;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=epidermal%20keratinocytes;cell%20sex=U;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000072;replicate=1,3,2;softwareversion=ScriptureVPaperR3; 575 . 58819700 58819743 76,255,0
chrY 58819704 58819741 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 471 . 58819704 58819741 0,255,29
chrY 58972897 58973005 ID=SRX5431823;Name=H3K9me1%20(@%20hESC%20derived%20endodermal%20cells);Title=GSM3630267:%20hDE%20FOXA2gRNA%20H3K27me3%20rep2%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Pluripotent%20stem%20cell;
source_name=Definitive%20endoderm;cell_line=H1;assay=H3K27me3;treatment%20protocol=FOXA2%20gRNA;chip%20antibody=Millipore,%2007-450; 542 . 58972897 58973005 42,255,0
chrY 58996927 58997046 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 548 . 58996927 58997046 48,255,0
chrY 59363067 59363364 ID=SRX6818882;Name=H3K9me1%20(@%20NB-4);Title=GSM4067001:%20shKDM3B%20H3K9me1%20ChIP-seq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Blood;
source_name=NB4%20cell%20line;cell%20line=NB4;cell%20type=Leukemic%20cells;chip%20antibody=H3K9me1%20(Active%20Motif,%2039887,lot%2026010001); 703 . 59363067 59363364 207,255,0
chrY 59363077 59363378 ID=SRX7115496;Name=H3K9me1%20(@%20RH-4);Title=GSM4154586:%20RH4%20H3K9me1%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Muscle;
source_name=RH4;cell%20line=RH4;antibody=H3K9me1,%20Active%20Motif%20(cat39887%20lot04413002%20pAb);enrichment%20target=H3K9me1;condition=Histone%20Mark;target%20function=no%20treatment; 1000 . 59363077 59363378 255,0,0
chrY 59363084 59363334 ID=SRX6964225;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113897:%2024hrA%20H3K9me1ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 563 . 59363084 59363334 64,255,0
chrY 59363105 59363209 ID=SRX6964226;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113898:%2024hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 277 . 59363105 59363209 0,255,227
chrY 59363139 59363242 ID=SRX6964224;Name=H3K9me1%20(@%20HCT%20116);Title=GSM4113896:%200hrB%20H3K9me1%20ChIPSeq%3B%20Homo%20sapiens%3B%20ChIP-Seq;Cell%20group=Digestive%20tract;
source_name=HCT116%20cells;cell%20line=HCT116%20cells;cell%20type=colorectal%20carcinoma;passages=19;chip%20antibody=H3K9me1%20(Abcam,%20Rb%20mAb%20Cat#176880; 261 . 59363139 59363242 0,255,243
chrY 59363140 59363208 ID=SRX067528;Name=H3K9me1%20(@%20K-562);Title=GSM733777:%20Bernstein%20K562%20H3K9me1;Cell%20group=Blood;
source_name=K562;biomaterial_provider=ATCC;lab=Broad;lab%20description=Bernstein%20-%20Broad%20Institute;datatype=ChipSeq;datatype%20description=Chromatin%20IP%20Sequencing;cell%20organism=human;cell%20description=leukemia,%20%22The%20continuous%20cell%20line%20K-562%20was%20established%20by%20Lozzio%20and%20Lozzio%20from%20the%20pleural%20effusion%20of%20a%2053-year-old%20female%20with%20chronic%20myelogenous%20leukemia%20in%20terminal%20blast%20crises.%22%20-%20ATCC;cell%20lineage=mesoderm;antibody%20antibodydescription=rabbit%20polyclonal.%20Antibody%20Target:%20H3K9me1;antibody%20targetdescription=Histone%20H3%20(mono-methyl%20K9).%20Is%20associated%20with%20active%20and%20accessible%20regions.%20NOTE%20CONTRAST%20to%20H3K9me3%20which%20is%20associated%20with%20repressive%20heterochromatic%20state.;antibody%20vendorname=abcam;antibody%20vendorid=ab8896;treatment=None;treatment%20description=No%20special%20treatment%20or%20protocol%20applies;control=std;control%20description=Standard%20input%20signal%20for%20most%20experiments.;controlid=wgEncodeEH000052;labversion=Illumina_GA2e%20and%20Illumina_GA2x;replicate=1;softwareversion=ScriptureVPaperR3; 252 . 59363140 59363208 0,255,252